CASRN	ADVERSE_EFFECT|BBM_1_Anemia	ADVERSE_EFFECT|BBM_1_Red Blood Cell Damage	ADVERSE_EFFECT|DNA_1_Carcinogenicity	ADVERSE_EFFECT|DNA_2_Genotoxicity	ADVERSE_EFFECT|EMB_1_Teratogenicity	ADVERSE_EFFECT|IMU_1_Suppressed Immune System	CTD_CHEM2DISEASE|Abnormalities, Drug-Induced	CTD_CHEM2DISEASE|Abnormalities, Multiple	CTD_CHEM2DISEASE|Adenocarcinoma	CTD_CHEM2DISEASE|Adenocarcinoma of lung	CTD_CHEM2DISEASE|Adenoma	CTD_CHEM2DISEASE|Anemia	CTD_CHEM2DISEASE|Anus Neoplasms	CTD_CHEM2DISEASE|Aortic Aneurysm, Abdominal	CTD_CHEM2DISEASE|Arrhythmias, Cardiac	CTD_CHEM2DISEASE|Arteriosclerosis	CTD_CHEM2DISEASE|Asthma	CTD_CHEM2DISEASE|Atherosclerosis	CTD_CHEM2DISEASE|Bradycardia	CTD_CHEM2DISEASE|Breast Neoplasms	CTD_CHEM2DISEASE|Carcinoma	CTD_CHEM2DISEASE|Carcinoma in Situ	CTD_CHEM2DISEASE|Carcinoma, Hepatocellular	CTD_CHEM2DISEASE|Carcinoma, Squamous Cell	CTD_CHEM2DISEASE|Cardiomegaly	CTD_CHEM2DISEASE|Cardiovascular Abnormalities	CTD_CHEM2DISEASE|Cell Transformation, Neoplastic	CTD_CHEM2DISEASE|Chromosome Aberrations	CTD_CHEM2DISEASE|Congenital Abnormalities	CTD_CHEM2DISEASE|Craniofacial Abnormalities	CTD_CHEM2DISEASE|Drug-Induced Liver Injury	CTD_CHEM2DISEASE|Edema	CTD_CHEM2DISEASE|Esophageal Neoplasms	CTD_CHEM2DISEASE|Fatty Liver	CTD_CHEM2DISEASE|Fetal Growth Retardation	CTD_CHEM2DISEASE|Glycosylphosphatidylinositol deficiency	CTD_CHEM2DISEASE|Heart Defects, Congenital	CTD_CHEM2DISEASE|Heart Diseases	CTD_CHEM2DISEASE|Hemangioendothelioma	CTD_CHEM2DISEASE|Hemolysis	CTD_CHEM2DISEASE|Hepatomegaly	CTD_CHEM2DISEASE|Histiocytoma, Malignant Fibrous	CTD_CHEM2DISEASE|Hyperplasia	CTD_CHEM2DISEASE|Hypertrophy	CTD_CHEM2DISEASE|Immune System Diseases	CTD_CHEM2DISEASE|Immunologic Deficiency Syndromes	CTD_CHEM2DISEASE|Infertility, Female	CTD_CHEM2DISEASE|Inflammation	CTD_CHEM2DISEASE|Intestinal Neoplasms	CTD_CHEM2DISEASE|Kidney Diseases	CTD_CHEM2DISEASE|Kidney Neoplasms	CTD_CHEM2DISEASE|Laryngeal Neoplasms	CTD_CHEM2DISEASE|Learning Disorders	CTD_CHEM2DISEASE|Liver Diseases	CTD_CHEM2DISEASE|Liver Neoplasms	CTD_CHEM2DISEASE|Liver Neoplasms, Experimental	CTD_CHEM2DISEASE|Lung Injury	CTD_CHEM2DISEASE|Lung Neoplasms	CTD_CHEM2DISEASE|Lymphoma	CTD_CHEM2DISEASE|Mammary Neoplasms, Animal	CTD_CHEM2DISEASE|Memory Disorders	CTD_CHEM2DISEASE|Mesothelioma	CTD_CHEM2DISEASE|Micronuclei, Chromosome-Defective	CTD_CHEM2DISEASE|Microsatellite Instability	CTD_CHEM2DISEASE|Mouth Neoplasms	CTD_CHEM2DISEASE|Necrosis	CTD_CHEM2DISEASE|Neoplasm Invasiveness	CTD_CHEM2DISEASE|Neoplasms	CTD_CHEM2DISEASE|Neoplasms, Experimental	CTD_CHEM2DISEASE|Nervous System Malformations	CTD_CHEM2DISEASE|Neural Tube Defects	CTD_CHEM2DISEASE|Neurobehavioral Manifestations	CTD_CHEM2DISEASE|Neurotoxicity Syndromes	CTD_CHEM2DISEASE|Non-alcoholic Fatty Liver Disease	CTD_CHEM2DISEASE|Nose Neoplasms	CTD_CHEM2DISEASE|Oligospermia	CTD_CHEM2DISEASE|Ovarian epithelial cancer	CTD_CHEM2DISEASE|Papilloma	CTD_CHEM2DISEASE|Pericardial Effusion	CTD_CHEM2DISEASE|Pharyngeal Neoplasms	CTD_CHEM2DISEASE|Placenta Diseases	CTD_CHEM2DISEASE|Poisoning	CTD_CHEM2DISEASE|Precancerous Conditions	CTD_CHEM2DISEASE|Prenatal Exposure Delayed Effects	CTD_CHEM2DISEASE|Prenatal Injuries	CTD_CHEM2DISEASE|Primary Ovarian Insufficiency	CTD_CHEM2DISEASE|Prostatic Neoplasms	CTD_CHEM2DISEASE|Psychomotor Disorders	CTD_CHEM2DISEASE|Sarcoma	CTD_CHEM2DISEASE|Skin Neoplasms	CTD_CHEM2DISEASE|Stomach Neoplasms	CTD_CHEM2DISEASE|Testicular Diseases	CTD_CHEM2DISEASE|Tongue Neoplasms	CTD_CHEM2DISEASE|Urinary Bladder Neoplasms	CTD_CHEM2DISEASE|Uterine Cervical Neoplasms	CTD_CHEM2DISEASE|Uterine Diseases	CTD_CHEM2DISEASE|Weight Gain	CTD_CHEM2DISEASE|Weight Loss	CTD_CHEM2GENE_25|ACOX1	CTD_CHEM2GENE_25|ACOX2	CTD_CHEM2GENE_25|AHR	CTD_CHEMICALS_DISEASES|46,Xy Gonadal Dysgenesis, Partial, With Minifascicular Neuropathy	CTD_CHEMICALS_DISEASES|Abnormalities, Multiple	CTD_CHEMICALS_DISEASES|Abortion, Spontaneous	CTD_CHEMICALS_DISEASES|Acid Phosphatase Deficiency	CTD_CHEMICALS_DISEASES|Acne Vulgaris	CTD_CHEMICALS_DISEASES|Activated Protein C Resistance	CTD_CHEMICALS_DISEASES|Acute Kidney Injury	CTD_CHEMICALS_DISEASES|Acute Lung Injury	CTD_CHEMICALS_DISEASES|Adenocarcinoma	CTD_CHEMICALS_DISEASES|Adenocarcinoma Of Esophagus	CTD_CHEMICALS_DISEASES|Adenocarcinoma of Lung	CTD_CHEMICALS_DISEASES|Adenomatous Polyposis Coli	CTD_CHEMICALS_DISEASES|Adrenal Gland Neoplasms	CTD_CHEMICALS_DISEASES|Adrenal Hyperplasia, Congenital	CTD_CHEMICALS_DISEASES|Adrenocortical Carcinoma	CTD_CHEMICALS_DISEASES|Advanced Sleep-Phase Syndrome, Familial	CTD_CHEMICALS_DISEASES|Agammaglobulinemia	CTD_CHEMICALS_DISEASES|Agricultural Workers' Diseases	CTD_CHEMICALS_DISEASES|Aicardi-Goutieres syndrome	CTD_CHEMICALS_DISEASES|Airway Obstruction	CTD_CHEMICALS_DISEASES|Albuminuria	CTD_CHEMICALS_DISEASES|Alcoholism	CTD_CHEMICALS_DISEASES|Alzheimer Disease	CTD_CHEMICALS_DISEASES|Amenorrhea	CTD_CHEMICALS_DISEASES|Amino Acid Metabolism, Inborn Errors	CTD_CHEMICALS_DISEASES|Amphetamine-Related Disorders	CTD_CHEMICALS_DISEASES|Amyotrophic Lateral Sclerosis	CTD_CHEMICALS_DISEASES|Amyotrophic lateral sclerosis 1	CTD_CHEMICALS_DISEASES|Anemia, Dyserythropoietic, Congenital	CTD_CHEMICALS_DISEASES|Anemia, Hemolytic, Autoimmune	CTD_CHEMICALS_DISEASES|Anemia, Refractory	CTD_CHEMICALS_DISEASES|Angina, Stable	CTD_CHEMICALS_DISEASES|Angina, Unstable	CTD_CHEMICALS_DISEASES|Anterior segment mesenchymal dysgenesis	CTD_CHEMICALS_DISEASES|Aortic Aneurysm, Abdominal	CTD_CHEMICALS_DISEASES|Aortic Diseases	CTD_CHEMICALS_DISEASES|Aortic Valve Disease 1	CTD_CHEMICALS_DISEASES|Aortic Valve Insufficiency	CTD_CHEMICALS_DISEASES|Aortic Valve, Calcification of	CTD_CHEMICALS_DISEASES|Arrhythmias, Cardiac	CTD_CHEMICALS_DISEASES|Arsenic Poisoning	CTD_CHEMICALS_DISEASES|Arteriosclerosis	CTD_CHEMICALS_DISEASES|Arthritis, Experimental	CTD_CHEMICALS_DISEASES|Arthritis, Infectious	CTD_CHEMICALS_DISEASES|Arthritis, Juvenile	CTD_CHEMICALS_DISEASES|Arthritis, Psoriatic	CTD_CHEMICALS_DISEASES|Arthritis, Rheumatoid	CTD_CHEMICALS_DISEASES|Asbestosis	CTD_CHEMICALS_DISEASES|Ascites	CTD_CHEMICALS_DISEASES|Asphyxia Neonatorum	CTD_CHEMICALS_DISEASES|Asthma	CTD_CHEMICALS_DISEASES|Asthma, Aspirin-Induced	CTD_CHEMICALS_DISEASES|Asthma, Occupational	CTD_CHEMICALS_DISEASES|Astrocytoma	CTD_CHEMICALS_DISEASES|Atherosclerosis	CTD_CHEMICALS_DISEASES|Atrial Fibrillation	CTD_CHEMICALS_DISEASES|Atrioventricular Septal Defect	CTD_CHEMICALS_DISEASES|Atrophy	CTD_CHEMICALS_DISEASES|Autism Spectrum Disorder	CTD_CHEMICALS_DISEASES|Autistic Disorder	CTD_CHEMICALS_DISEASES|Azotemia	CTD_CHEMICALS_DISEASES|Barrett Esophagus	CTD_CHEMICALS_DISEASES|Basal Ganglia Diseases	CTD_CHEMICALS_DISEASES|Beckwith-Wiedemann Syndrome	CTD_CHEMICALS_DISEASES|Behcet Syndrome	CTD_CHEMICALS_DISEASES|Berylliosis	CTD_CHEMICALS_DISEASES|Birth Weight	CTD_CHEMICALS_DISEASES|Bone Diseases, Metabolic	CTD_CHEMICALS_DISEASES|Bone Resorption	CTD_CHEMICALS_DISEASES|Bowen's Disease	CTD_CHEMICALS_DISEASES|Brain Diseases	CTD_CHEMICALS_DISEASES|Brain Injuries	CTD_CHEMICALS_DISEASES|Brain Injuries, Traumatic	CTD_CHEMICALS_DISEASES|Brain Ischemia	CTD_CHEMICALS_DISEASES|Brain Neoplasms	CTD_CHEMICALS_DISEASES|Breast Neoplasms	CTD_CHEMICALS_DISEASES|Breast Neoplasms, Male	CTD_CHEMICALS_DISEASES|Bronchiectasis	CTD_CHEMICALS_DISEASES|Brugada Syndrome 6	CTD_CHEMICALS_DISEASES|Burns	CTD_CHEMICALS_DISEASES|Burns, Chemical	CTD_CHEMICALS_DISEASES|CATARACT 43	CTD_CHEMICALS_DISEASES|COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	CTD_CHEMICALS_DISEASES|COMPLEMENT COMPONENT 2 DEFICIENCY	CTD_CHEMICALS_DISEASES|COMPLEMENT COMPONENT 4B DEFICIENCY	CTD_CHEMICALS_DISEASES|CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6	CTD_CHEMICALS_DISEASES|COVID-19	CTD_CHEMICALS_DISEASES|COWDEN SYNDROME 7	CTD_CHEMICALS_DISEASES|Cachexia	CTD_CHEMICALS_DISEASES|Calcinosis	CTD_CHEMICALS_DISEASES|Carcinoma	CTD_CHEMICALS_DISEASES|Carcinoma, Ductal, Breast	CTD_CHEMICALS_DISEASES|Carcinoma, Hepatocellular	CTD_CHEMICALS_DISEASES|Carcinoma, Intraductal, Noninfiltrating	CTD_CHEMICALS_DISEASES|Carcinoma, Large Cell	CTD_CHEMICALS_DISEASES|Carcinoma, Lobular	CTD_CHEMICALS_DISEASES|Carcinoma, Non-Small-Cell Lung	CTD_CHEMICALS_DISEASES|Carcinoma, Ovarian Epithelial	CTD_CHEMICALS_DISEASES|Carcinoma, Pancreatic Ductal	CTD_CHEMICALS_DISEASES|Carcinoma, Transitional Cell	CTD_CHEMICALS_DISEASES|Cardiomegaly	CTD_CHEMICALS_DISEASES|Cardiomyopathies	CTD_CHEMICALS_DISEASES|Cardiomyopathy, Hypertrophic	CTD_CHEMICALS_DISEASES|Cardiomyopathy, Hypertrophic, Familial	CTD_CHEMICALS_DISEASES|Cardiotoxicity	CTD_CHEMICALS_DISEASES|Cardiovascular Diseases	CTD_CHEMICALS_DISEASES|Carotid Artery Diseases	CTD_CHEMICALS_DISEASES|Cataract, Autosomal Dominant, Multiple Types 1	CTD_CHEMICALS_DISEASES|Cecal Neoplasms	CTD_CHEMICALS_DISEASES|Celiac Disease	CTD_CHEMICALS_DISEASES|Cell Transformation, Neoplastic	CTD_CHEMICALS_DISEASES|Ceroid lipofuscinosis, neuronal 1, infantile	CTD_CHEMICALS_DISEASES|Charcot-Marie-Tooth disease, Type 2J	CTD_CHEMICALS_DISEASES|Chemical and Drug Induced Liver Injury	CTD_CHEMICALS_DISEASES|Chlamydia Infections	CTD_CHEMICALS_DISEASES|Chloracne	CTD_CHEMICALS_DISEASES|Cholangiocarcinoma	CTD_CHEMICALS_DISEASES|Cholangitis	CTD_CHEMICALS_DISEASES|Cholestasis	CTD_CHEMICALS_DISEASES|Cholestasis, Extrahepatic	CTD_CHEMICALS_DISEASES|Chondrosarcoma, Mesenchymal	CTD_CHEMICALS_DISEASES|Cleft Lip	CTD_CHEMICALS_DISEASES|Cleft Palate	CTD_CHEMICALS_DISEASES|Clinical Deterioration	CTD_CHEMICALS_DISEASES|Cocaine-Related Disorders	CTD_CHEMICALS_DISEASES|Coffin-Siris syndrome	CTD_CHEMICALS_DISEASES|Cognition Disorders	CTD_CHEMICALS_DISEASES|Colitis	CTD_CHEMICALS_DISEASES|Colitis, Ulcerative	CTD_CHEMICALS_DISEASES|Coloboma	CTD_CHEMICALS_DISEASES|Colorectal Neoplasms	CTD_CHEMICALS_DISEASES|Common Variable Immunodeficiency	CTD_CHEMICALS_DISEASES|Congenital Disorder of Glycosylation, Type Io	CTD_CHEMICALS_DISEASES|Copper-Overload Cirrhosis	CTD_CHEMICALS_DISEASES|Corneal Neovascularization	CTD_CHEMICALS_DISEASES|Coronary Artery Disease	CTD_CHEMICALS_DISEASES|Coronary Restenosis	CTD_CHEMICALS_DISEASES|Coumarin Resistance	CTD_CHEMICALS_DISEASES|Coxsackievirus Infections	CTD_CHEMICALS_DISEASES|Craniofacial Abnormalities	CTD_CHEMICALS_DISEASES|Craniofrontonasal dysplasia	CTD_CHEMICALS_DISEASES|Craniosynostoses	CTD_CHEMICALS_DISEASES|Critical Illness	CTD_CHEMICALS_DISEASES|Crohn Disease	CTD_CHEMICALS_DISEASES|Cystic Kidney Disease with Ventriculomegaly	CTD_CHEMICALS_DISEASES|DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;DFNB36 DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT,	CTD_CHEMICALS_DISEASES|DIABETES MELLITUS, NONINSULIN-DEPENDENT, 5	CTD_CHEMICALS_DISEASES|Deafness	CTD_CHEMICALS_DISEASES|Depressive Disorder, Major	CTD_CHEMICALS_DISEASES|Dermatitis	CTD_CHEMICALS_DISEASES|Dermatitis, Allergic Contact	CTD_CHEMICALS_DISEASES|Dermatitis, Atopic	CTD_CHEMICALS_DISEASES|Dermatitis, Contact	CTD_CHEMICALS_DISEASES|Dermatitis, Irritant	CTD_CHEMICALS_DISEASES|Dermatitis, Occupational	CTD_CHEMICALS_DISEASES|Dermatomyositis	CTD_CHEMICALS_DISEASES|Developmental Disabilities	CTD_CHEMICALS_DISEASES|Diabetes Mellitus	CTD_CHEMICALS_DISEASES|Diabetes Mellitus, Experimental	CTD_CHEMICALS_DISEASES|Diabetes Mellitus, Type 1	CTD_CHEMICALS_DISEASES|Diabetes Mellitus, Type 2	CTD_CHEMICALS_DISEASES|Diabetes, Gestational	CTD_CHEMICALS_DISEASES|Diabetic Angiopathies	CTD_CHEMICALS_DISEASES|Diabetic Nephropathies	CTD_CHEMICALS_DISEASES|Diabetic Neuropathies	CTD_CHEMICALS_DISEASES|Disease Models, Animal	CTD_CHEMICALS_DISEASES|Disease Progression	CTD_CHEMICALS_DISEASES|Disruptive, Impulse Control, and Conduct Disorders	CTD_CHEMICALS_DISEASES|Diverticular Diseases	CTD_CHEMICALS_DISEASES|Down Syndrome	CTD_CHEMICALS_DISEASES|Drug-Related Side Effects and Adverse Reactions	CTD_CHEMICALS_DISEASES|Dysfibrinogenemia, Congenital	CTD_CHEMICALS_DISEASES|Dyskinesias	CTD_CHEMICALS_DISEASES|ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE	CTD_CHEMICALS_DISEASES|Edema	CTD_CHEMICALS_DISEASES|Ehlers-Danlos Syndrome, Type VII, Autosomal Dominant	CTD_CHEMICALS_DISEASES|Endometrial Neoplasms	CTD_CHEMICALS_DISEASES|Entamoebiasis	CTD_CHEMICALS_DISEASES|Epilepsy	CTD_CHEMICALS_DISEASES|Epilepsy, Idiopathic Generalized	CTD_CHEMICALS_DISEASES|Esophageal Neoplasms	CTD_CHEMICALS_DISEASES|Esophageal Squamous Cell Carcinoma	CTD_CHEMICALS_DISEASES|Esophagitis, Peptic	CTD_CHEMICALS_DISEASES|Eye Diseases	CTD_CHEMICALS_DISEASES|Eye Infections, Bacterial	CTD_CHEMICALS_DISEASES|Facies	CTD_CHEMICALS_DISEASES|Familial Primary Pulmonary Hypertension	CTD_CHEMICALS_DISEASES|Fanconi Anemia, Complementation Group D1	CTD_CHEMICALS_DISEASES|Fatty Liver	CTD_CHEMICALS_DISEASES|Feeding and Eating Disorders	CTD_CHEMICALS_DISEASES|Feminization	CTD_CHEMICALS_DISEASES|Femur Head Necrosis	CTD_CHEMICALS_DISEASES|Fetal Alcohol Spectrum Disorders	CTD_CHEMICALS_DISEASES|Fever	CTD_CHEMICALS_DISEASES|Fibrosis	CTD_CHEMICALS_DISEASES|Fractures, Bone	CTD_CHEMICALS_DISEASES|Frontotemporal Lobar Degeneration	CTD_CHEMICALS_DISEASES|Gait Disorders, Neurologic	CTD_CHEMICALS_DISEASES|Gastroesophageal Reflux	CTD_CHEMICALS_DISEASES|Genetic Predisposition to Disease	CTD_CHEMICALS_DISEASES|Genomic Instability	CTD_CHEMICALS_DISEASES|Glaucoma 3, Primary Congenital, A	CTD_CHEMICALS_DISEASES|Glaucoma 3, primary infantile, B	CTD_CHEMICALS_DISEASES|Glioblastoma	CTD_CHEMICALS_DISEASES|Glioma	CTD_CHEMICALS_DISEASES|Gliosis	CTD_CHEMICALS_DISEASES|Glomerulonephritis	CTD_CHEMICALS_DISEASES|Glomerulonephritis, IGA	CTD_CHEMICALS_DISEASES|Glucose Intolerance	CTD_CHEMICALS_DISEASES|Graves Ophthalmopathy	CTD_CHEMICALS_DISEASES|Growth Disorders	CTD_CHEMICALS_DISEASES|HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO	CTD_CHEMICALS_DISEASES|HIV Infections	CTD_CHEMICALS_DISEASES|HIV Wasting Syndrome	CTD_CHEMICALS_DISEASES|Hamartoma	CTD_CHEMICALS_DISEASES|Headache	CTD_CHEMICALS_DISEASES|Hearing Disorders	CTD_CHEMICALS_DISEASES|Heart Defects, Congenital	CTD_CHEMICALS_DISEASES|Heart Failure	CTD_CHEMICALS_DISEASES|Heart Failure, Diastolic	CTD_CHEMICALS_DISEASES|Heart Valve Diseases	CTD_CHEMICALS_DISEASES|Hemangioblastoma	CTD_CHEMICALS_DISEASES|Hemangiosarcoma	CTD_CHEMICALS_DISEASES|Hematologic Diseases	CTD_CHEMICALS_DISEASES|Hemolytic-Uremic Syndrome	CTD_CHEMICALS_DISEASES|Hepatic Veno-Occlusive Disease	CTD_CHEMICALS_DISEASES|Hepatitis B	CTD_CHEMICALS_DISEASES|Hepatitis, Alcoholic	CTD_CHEMICALS_DISEASES|Hepatitis, Animal	CTD_CHEMICALS_DISEASES|Hepatitis, Autoimmune	CTD_CHEMICALS_DISEASES|Hepatitis, Chronic	CTD_CHEMICALS_DISEASES|Hepatolenticular Degeneration	CTD_CHEMICALS_DISEASES|Hepatomegaly	CTD_CHEMICALS_DISEASES|Hereditary Breast and Ovarian Cancer Syndrome	CTD_CHEMICALS_DISEASES|Hereditary macular coloboma	CTD_CHEMICALS_DISEASES|Hereditary pancreatitis	CTD_CHEMICALS_DISEASES|Hermanski-Pudlak Syndrome	CTD_CHEMICALS_DISEASES|Hernia, Diaphragmatic	CTD_CHEMICALS_DISEASES|Hernias, Diaphragmatic, Congenital	CTD_CHEMICALS_DISEASES|Hirschsprung Disease	CTD_CHEMICALS_DISEASES|Hydronephrosis	CTD_CHEMICALS_DISEASES|Hyperalgesia	CTD_CHEMICALS_DISEASES|Hypercholanemia, Familial	CTD_CHEMICALS_DISEASES|Hyperemia	CTD_CHEMICALS_DISEASES|Hyperhomocysteinemia	CTD_CHEMICALS_DISEASES|Hyperlipoproteinemia Type II	CTD_CHEMICALS_DISEASES|Hyperoxia	CTD_CHEMICALS_DISEASES|Hyperparathyroidism	CTD_CHEMICALS_DISEASES|Hyperplasia	CTD_CHEMICALS_DISEASES|Hypersensitivity	CTD_CHEMICALS_DISEASES|Hypertension, Pulmonary	CTD_CHEMICALS_DISEASES|Hypertriglyceridemia	CTD_CHEMICALS_DISEASES|Hypertrophy	CTD_CHEMICALS_DISEASES|Hypertrophy, Left Ventricular	CTD_CHEMICALS_DISEASES|Hyperventilation	CTD_CHEMICALS_DISEASES|Hypocalcemia	CTD_CHEMICALS_DISEASES|Hypoglycemia	CTD_CHEMICALS_DISEASES|Hypophosphatasia	CTD_CHEMICALS_DISEASES|Hypopituitarism	CTD_CHEMICALS_DISEASES|Hypospadias 1, X-Linked	CTD_CHEMICALS_DISEASES|Hypothyroidism	CTD_CHEMICALS_DISEASES|Idiopathic Pulmonary Fibrosis	CTD_CHEMICALS_DISEASES|Immunologic Deficiency Syndromes	CTD_CHEMICALS_DISEASES|Inappropriate ADH Syndrome	CTD_CHEMICALS_DISEASES|Infarction, Middle Cerebral Artery	CTD_CHEMICALS_DISEASES|Infertility, Female	CTD_CHEMICALS_DISEASES|Infertility, Male	CTD_CHEMICALS_DISEASES|Inflammation	CTD_CHEMICALS_DISEASES|Inflammatory Bowel Diseases	CTD_CHEMICALS_DISEASES|Influenza, Human	CTD_CHEMICALS_DISEASES|Inosine Triphosphatase Deficiency	CTD_CHEMICALS_DISEASES|Insulin Resistance	CTD_CHEMICALS_DISEASES|Intellectual Disability	CTD_CHEMICALS_DISEASES|Intestinal Polyps	CTD_CHEMICALS_DISEASES|Intracranial Hypertension	CTD_CHEMICALS_DISEASES|Intrahepatic Cholestasis of Pregnancy	CTD_CHEMICALS_DISEASES|Iron Overload	CTD_CHEMICALS_DISEASES|Ischemia	CTD_CHEMICALS_DISEASES|Ischiopatellar dysplasia	CTD_CHEMICALS_DISEASES|Jaundice, Obstructive	CTD_CHEMICALS_DISEASES|Kallikrein, Decreased Urinary Activity of	CTD_CHEMICALS_DISEASES|Kearns-Sayre Syndrome	CTD_CHEMICALS_DISEASES|Keloid	CTD_CHEMICALS_DISEASES|Keratitis	CTD_CHEMICALS_DISEASES|Keratosis	CTD_CHEMICALS_DISEASES|Kidney Failure, Chronic	CTD_CHEMICALS_DISEASES|Kidney Neoplasms	CTD_CHEMICALS_DISEASES|Language Development Disorders	CTD_CHEMICALS_DISEASES|Late-Onset Retinal Degeneration	CTD_CHEMICALS_DISEASES|Leiomyoma	CTD_CHEMICALS_DISEASES|Leishmaniasis	CTD_CHEMICALS_DISEASES|Leishmaniasis, Cutaneous	CTD_CHEMICALS_DISEASES|Leishmaniasis, Visceral	CTD_CHEMICALS_DISEASES|Lens Diseases	CTD_CHEMICALS_DISEASES|Leukemia	CTD_CHEMICALS_DISEASES|Leukemia, Lymphocytic, Chronic, B-Cell	CTD_CHEMICALS_DISEASES|Leukemia, Myeloid, Acute	CTD_CHEMICALS_DISEASES|Leukemia, Promyelocytic, Acute	CTD_CHEMICALS_DISEASES|Leukemia-Lymphoma, Adult T-Cell	CTD_CHEMICALS_DISEASES|Leukokeratosis, Hereditary Mucosal	CTD_CHEMICALS_DISEASES|Leukoplakia, Oral	CTD_CHEMICALS_DISEASES|Leukostasis	CTD_CHEMICALS_DISEASES|Lewy Body Disease	CTD_CHEMICALS_DISEASES|Li-Fraumeni Syndrome	CTD_CHEMICALS_DISEASES|Lichenoid Eruptions	CTD_CHEMICALS_DISEASES|Lipid Metabolism, Inborn Errors	CTD_CHEMICALS_DISEASES|Liposarcoma, Myxoid	CTD_CHEMICALS_DISEASES|Liver Cirrhosis	CTD_CHEMICALS_DISEASES|Liver Cirrhosis, Alcoholic	CTD_CHEMICALS_DISEASES|Liver Cirrhosis, Biliary	CTD_CHEMICALS_DISEASES|Liver Cirrhosis, Experimental	CTD_CHEMICALS_DISEASES|Liver Diseases	CTD_CHEMICALS_DISEASES|Liver Diseases, Parasitic	CTD_CHEMICALS_DISEASES|Liver Failure, Acute	CTD_CHEMICALS_DISEASES|Liver Neoplasms	CTD_CHEMICALS_DISEASES|Liver Neoplasms, Experimental	CTD_CHEMICALS_DISEASES|Loeys-Dietz Syndrome	CTD_CHEMICALS_DISEASES|Lung Diseases	CTD_CHEMICALS_DISEASES|Lung Injury	CTD_CHEMICALS_DISEASES|Lupus Erythematosus, Systemic	CTD_CHEMICALS_DISEASES|Lymphatic Metastasis	CTD_CHEMICALS_DISEASES|Lymphoma, Mantle-Cell	CTD_CHEMICALS_DISEASES|Lymphoma, T-Cell, Cutaneous	CTD_CHEMICALS_DISEASES|MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION	CTD_CHEMICALS_DISEASES|MACULAR DEGENERATION, AGE-RELATED, 12	CTD_CHEMICALS_DISEASES|MACULAR DEGENERATION, AGE-RELATED, 14	CTD_CHEMICALS_DISEASES|MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME	CTD_CHEMICALS_DISEASES|MELAS Syndrome	CTD_CHEMICALS_DISEASES|MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36	CTD_CHEMICALS_DISEASES|MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57	CTD_CHEMICALS_DISEASES|MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	CTD_CHEMICALS_DISEASES|MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	CTD_CHEMICALS_DISEASES|MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO	CTD_CHEMICALS_DISEASES|Macrocephaly Autism Syndrome	CTD_CHEMICALS_DISEASES|Macular Degeneration	CTD_CHEMICALS_DISEASES|Malaria	CTD_CHEMICALS_DISEASES|Mammary Neoplasms, Animal	CTD_CHEMICALS_DISEASES|Mammary Neoplasms, Experimental	CTD_CHEMICALS_DISEASES|Manganese Poisoning	CTD_CHEMICALS_DISEASES|Maple Syrup Urine Disease	CTD_CHEMICALS_DISEASES|Marden-Walker syndrome	CTD_CHEMICALS_DISEASES|Marfan Syndrome	CTD_CHEMICALS_DISEASES|Mastocytosis	CTD_CHEMICALS_DISEASES|Meier-Gorlin syndrome	CTD_CHEMICALS_DISEASES|Melanoma	CTD_CHEMICALS_DISEASES|Meningitis, Meningococcal	CTD_CHEMICALS_DISEASES|Meningomyelocele	CTD_CHEMICALS_DISEASES|Mental Retardation, Autosomal Recessive 7	CTD_CHEMICALS_DISEASES|Mental Retardation, X-Linked 93	CTD_CHEMICALS_DISEASES|Mesothelioma	CTD_CHEMICALS_DISEASES|Mesothelioma, Malignant	CTD_CHEMICALS_DISEASES|Metabolic Diseases	CTD_CHEMICALS_DISEASES|Metabolic Syndrome	CTD_CHEMICALS_DISEASES|Metabolism, Inborn Errors	CTD_CHEMICALS_DISEASES|Metaphyseal Dysplasia without Hypotrichosis	CTD_CHEMICALS_DISEASES|Methemoglobinemia	CTD_CHEMICALS_DISEASES|Methylmalonic acidemia	CTD_CHEMICALS_DISEASES|Mevalonate Kinase Deficiency	CTD_CHEMICALS_DISEASES|Micronuclei, Chromosome-Defective	CTD_CHEMICALS_DISEASES|Microsatellite Instability	CTD_CHEMICALS_DISEASES|Mitochondrial Myopathies	CTD_CHEMICALS_DISEASES|Mouth Diseases	CTD_CHEMICALS_DISEASES|Mouth Neoplasms	CTD_CHEMICALS_DISEASES|Multiple Myeloma	CTD_CHEMICALS_DISEASES|Muscular Atrophy	CTD_CHEMICALS_DISEASES|Muscular Dystrophies, Limb-Girdle	CTD_CHEMICALS_DISEASES|Muscular Dystrophy, Emery-Dreifuss	CTD_CHEMICALS_DISEASES|Muscular Dystrophy, Limb-Girdle, Type 1F	CTD_CHEMICALS_DISEASES|Musculoskeletal Pain	CTD_CHEMICALS_DISEASES|Mycoplasma Infections	CTD_CHEMICALS_DISEASES|Myelodysplastic Syndromes	CTD_CHEMICALS_DISEASES|Myocardial Infarction	CTD_CHEMICALS_DISEASES|Myocardial Ischemia	CTD_CHEMICALS_DISEASES|Myocardial Reperfusion Injury	CTD_CHEMICALS_DISEASES|Myopathies, Structural, Congenital	CTD_CHEMICALS_DISEASES|NEMALINE MYOPATHY 3;NEM3 MYOPATHY, ACTIN, CONGENITAL, WITH EXCESS OF THIN MYOFILAMENTS,	CTD_CHEMICALS_DISEASES|NESTOR-GUILLERMO PROGERIA SYNDROME	CTD_CHEMICALS_DISEASES|NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC	CTD_CHEMICALS_DISEASES|Narcolepsy 1	CTD_CHEMICALS_DISEASES|Nasopharyngeal Carcinoma	CTD_CHEMICALS_DISEASES|Nasopharyngeal Neoplasms	CTD_CHEMICALS_DISEASES|Nausea	CTD_CHEMICALS_DISEASES|Necrosis	CTD_CHEMICALS_DISEASES|Nemaline Myopathy 2	CTD_CHEMICALS_DISEASES|Neointima	CTD_CHEMICALS_DISEASES|Neoplasm Invasiveness	CTD_CHEMICALS_DISEASES|Neoplasm Metastasis	CTD_CHEMICALS_DISEASES|Neoplasm Recurrence, Local	CTD_CHEMICALS_DISEASES|Neoplasms	CTD_CHEMICALS_DISEASES|Neoplasms, Experimental	CTD_CHEMICALS_DISEASES|Nephrosclerosis	CTD_CHEMICALS_DISEASES|Nervous System Diseases	CTD_CHEMICALS_DISEASES|Neural Tube Defects	CTD_CHEMICALS_DISEASES|Neuroblastoma	CTD_CHEMICALS_DISEASES|Neurodegenerative Diseases	CTD_CHEMICALS_DISEASES|Neurodevelopmental Disorders	CTD_CHEMICALS_DISEASES|Neurogenic Inflammation	CTD_CHEMICALS_DISEASES|Neuromuscular Diseases	CTD_CHEMICALS_DISEASES|Neuronopathy, Distal Hereditary Motor, Type V	CTD_CHEMICALS_DISEASES|Neuropathy ataxia and retinitis pigmentosa	CTD_CHEMICALS_DISEASES|Non-alcoholic Fatty Liver Disease	CTD_CHEMICALS_DISEASES|Noonan Syndrome	CTD_CHEMICALS_DISEASES|Nystagmus, Congenital	CTD_CHEMICALS_DISEASES|OROFACIODIGITAL SYNDROME XIV	CTD_CHEMICALS_DISEASES|Obesity	CTD_CHEMICALS_DISEASES|Occupational Diseases	CTD_CHEMICALS_DISEASES|Ocular Hypertension	CTD_CHEMICALS_DISEASES|Oculodigitoesophagoduodenal syndrome	CTD_CHEMICALS_DISEASES|Oligodendroglioma	CTD_CHEMICALS_DISEASES|Oligospermia	CTD_CHEMICALS_DISEASES|Oliguria	CTD_CHEMICALS_DISEASES|Ophthalmoplegia, Chronic Progressive External	CTD_CHEMICALS_DISEASES|Opisthorchiasis	CTD_CHEMICALS_DISEASES|Optic Atrophy, Hereditary, Leber	CTD_CHEMICALS_DISEASES|Oral Submucous Fibrosis	CTD_CHEMICALS_DISEASES|Organophosphate Poisoning	CTD_CHEMICALS_DISEASES|Osteitis Deformans	CTD_CHEMICALS_DISEASES|Osteoarthritis	CTD_CHEMICALS_DISEASES|Osteochondrodysplasias	CTD_CHEMICALS_DISEASES|Osteogenesis Imperfecta, Type IV	CTD_CHEMICALS_DISEASES|Osteoporosis	CTD_CHEMICALS_DISEASES|Osteoporosis, Postmenopausal	CTD_CHEMICALS_DISEASES|Osteosarcoma	CTD_CHEMICALS_DISEASES|Ovarian Cysts	CTD_CHEMICALS_DISEASES|Ovarian Neoplasms	CTD_CHEMICALS_DISEASES|PEROXISOME BIOGENESIS DISORDER 10B	CTD_CHEMICALS_DISEASES|POROKERATOSIS 7, MULTIPLE TYPES	CTD_CHEMICALS_DISEASES|Pain	CTD_CHEMICALS_DISEASES|Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and Sex Reversal	CTD_CHEMICALS_DISEASES|Pancreatic Neoplasms	CTD_CHEMICALS_DISEASES|Pancreatic cancer, adult	CTD_CHEMICALS_DISEASES|Pancreatitis, Chronic	CTD_CHEMICALS_DISEASES|Papilloma	CTD_CHEMICALS_DISEASES|Paranoid Disorders	CTD_CHEMICALS_DISEASES|Parkinson Disease	CTD_CHEMICALS_DISEASES|Peanut Hypersensitivity	CTD_CHEMICALS_DISEASES|Pemphigoid, Bullous	CTD_CHEMICALS_DISEASES|Pendred syndrome	CTD_CHEMICALS_DISEASES|Peritoneal Neoplasms	CTD_CHEMICALS_DISEASES|Pheochromocytoma	CTD_CHEMICALS_DISEASES|Pierson syndrome	CTD_CHEMICALS_DISEASES|Pleural Diseases	CTD_CHEMICALS_DISEASES|Pleurisy	CTD_CHEMICALS_DISEASES|Pneumonia	CTD_CHEMICALS_DISEASES|Pneumonia, Pneumococcal	CTD_CHEMICALS_DISEASES|Polycystic Kidney, Autosomal Recessive	CTD_CHEMICALS_DISEASES|Polycystic Ovary Syndrome	CTD_CHEMICALS_DISEASES|Polymyositis	CTD_CHEMICALS_DISEASES|Porencephaly	CTD_CHEMICALS_DISEASES|Porphyria Cutanea Tarda	CTD_CHEMICALS_DISEASES|Pre-Eclampsia	CTD_CHEMICALS_DISEASES|Precancerous Conditions	CTD_CHEMICALS_DISEASES|Precursor Cell Lymphoblastic Leukemia-Lymphoma	CTD_CHEMICALS_DISEASES|Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	CTD_CHEMICALS_DISEASES|Pregnancy Complications, Cardiovascular	CTD_CHEMICALS_DISEASES|Premature Birth	CTD_CHEMICALS_DISEASES|Primary Graft Dysfunction	CTD_CHEMICALS_DISEASES|Primary Ovarian Insufficiency	CTD_CHEMICALS_DISEASES|Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Recessive	CTD_CHEMICALS_DISEASES|Prostate cancer, familial	CTD_CHEMICALS_DISEASES|Prostatic Intraepithelial Neoplasia	CTD_CHEMICALS_DISEASES|Prostatic Neoplasms	CTD_CHEMICALS_DISEASES|Prostatic Neoplasms, Castration-Resistant	CTD_CHEMICALS_DISEASES|Proteus Syndrome	CTD_CHEMICALS_DISEASES|Pruritus	CTD_CHEMICALS_DISEASES|Psoriasis	CTD_CHEMICALS_DISEASES|Psychotic Disorders	CTD_CHEMICALS_DISEASES|Puberty, Precocious	CTD_CHEMICALS_DISEASES|Pulmonary Disease, Chronic Obstructive	CTD_CHEMICALS_DISEASES|Pulmonary Emphysema	CTD_CHEMICALS_DISEASES|Pulmonary Fibrosis	CTD_CHEMICALS_DISEASES|Pulmonary Veno-Occlusive Disease	CTD_CHEMICALS_DISEASES|Pyridoxine-dependent epilepsy	CTD_CHEMICALS_DISEASES|RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME	CTD_CHEMICALS_DISEASES|Radiation Injuries, Experimental	CTD_CHEMICALS_DISEASES|Rectal Neoplasms	CTD_CHEMICALS_DISEASES|Recurrence	CTD_CHEMICALS_DISEASES|Reperfusion Injury	CTD_CHEMICALS_DISEASES|Respiratory Distress Syndrome, Adult	CTD_CHEMICALS_DISEASES|Respiratory Hypersensitivity	CTD_CHEMICALS_DISEASES|Respiratory Sounds	CTD_CHEMICALS_DISEASES|Respiratory Syncytial Virus Infections	CTD_CHEMICALS_DISEASES|Respiratory Tract Diseases	CTD_CHEMICALS_DISEASES|Respiratory Tract Infections	CTD_CHEMICALS_DISEASES|Retinal Degeneration	CTD_CHEMICALS_DISEASES|Retinal Diseases	CTD_CHEMICALS_DISEASES|Retinoschisis	CTD_CHEMICALS_DISEASES|SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	CTD_CHEMICALS_DISEASES|SPERMATOGENIC FAILURE 14	CTD_CHEMICALS_DISEASES|SPERMATOGENIC FAILURE, X-LINKED, 2	CTD_CHEMICALS_DISEASES|SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY	CTD_CHEMICALS_DISEASES|Salivary Gland Neoplasms	CTD_CHEMICALS_DISEASES|Salmonella Infections, Animal	CTD_CHEMICALS_DISEASES|Sarcoidosis	CTD_CHEMICALS_DISEASES|Sarcoma	CTD_CHEMICALS_DISEASES|Schizophrenia	CTD_CHEMICALS_DISEASES|Schizophrenia Spectrum and Other Psychotic Disorders	CTD_CHEMICALS_DISEASES|Scleroatonic muscular dystrophy	CTD_CHEMICALS_DISEASES|Sclerosteosis	CTD_CHEMICALS_DISEASES|Seizures	CTD_CHEMICALS_DISEASES|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	CTD_CHEMICALS_DISEASES|Sepsis	CTD_CHEMICALS_DISEASES|Severe Acute Respiratory Syndrome	CTD_CHEMICALS_DISEASES|Sexual Infantilism	CTD_CHEMICALS_DISEASES|Sezary Syndrome	CTD_CHEMICALS_DISEASES|Shock, Hemorrhagic	CTD_CHEMICALS_DISEASES|Sialorrhea	CTD_CHEMICALS_DISEASES|Silicosis	CTD_CHEMICALS_DISEASES|Skin Diseases	CTD_CHEMICALS_DISEASES|Skin Neoplasms	CTD_CHEMICALS_DISEASES|Sleep Disorders, Circadian Rhythm	CTD_CHEMICALS_DISEASES|Small Cell Lung Carcinoma	CTD_CHEMICALS_DISEASES|Spastic paraplegia 4, autosomal dominant	CTD_CHEMICALS_DISEASES|Spermatogenic Failure, Nonobstructive, Y-Linked	CTD_CHEMICALS_DISEASES|Spherocytosis, Hereditary	CTD_CHEMICALS_DISEASES|Spherocytosis, Type 4	CTD_CHEMICALS_DISEASES|Spinal Cord Compression	CTD_CHEMICALS_DISEASES|Spinal Cord Diseases	CTD_CHEMICALS_DISEASES|Spinal Cord Injuries	CTD_CHEMICALS_DISEASES|Spinocerebellar Ataxia 17	CTD_CHEMICALS_DISEASES|Spinocerebellar Ataxia 31	CTD_CHEMICALS_DISEASES|Splenic Diseases	CTD_CHEMICALS_DISEASES|Splenomegaly	CTD_CHEMICALS_DISEASES|Spondyloepimetaphyseal Dysplasia, Pakistani Type	CTD_CHEMICALS_DISEASES|Squamous Cell Carcinoma of Head and Neck	CTD_CHEMICALS_DISEASES|Staphylococcal Infections	CTD_CHEMICALS_DISEASES|Status Epilepticus	CTD_CHEMICALS_DISEASES|Stereotypic Movement Disorder	CTD_CHEMICALS_DISEASES|Stomach Neoplasms	CTD_CHEMICALS_DISEASES|Stomach Ulcer	CTD_CHEMICALS_DISEASES|Striatonigral degeneration infantile	CTD_CHEMICALS_DISEASES|Stroke	CTD_CHEMICALS_DISEASES|Subarachnoid Hemorrhage	CTD_CHEMICALS_DISEASES|Substance Withdrawal Syndrome	CTD_CHEMICALS_DISEASES|Substance-Related Disorders	CTD_CHEMICALS_DISEASES|Succinyl-CoA:3-oxoacid CoA transferase deficiency	CTD_CHEMICALS_DISEASES|Syndactyly Cenani Lenz type	CTD_CHEMICALS_DISEASES|TOBACCO ADDICTION, SUSCEPTIBILITY TO	CTD_CHEMICALS_DISEASES|TREMOR, HEREDITARY ESSENTIAL, 4	CTD_CHEMICALS_DISEASES|Tachycardia	CTD_CHEMICALS_DISEASES|Tachycardia, Supraventricular	CTD_CHEMICALS_DISEASES|Temporomandibular Joint Disorders	CTD_CHEMICALS_DISEASES|Testicular Germ Cell Tumor	CTD_CHEMICALS_DISEASES|Thrombophilia	CTD_CHEMICALS_DISEASES|Thrombosis	CTD_CHEMICALS_DISEASES|Thyroid Dyshormonogenesis 1	CTD_CHEMICALS_DISEASES|Thyroid Neoplasms	CTD_CHEMICALS_DISEASES|Tobacco Use Disorder	CTD_CHEMICALS_DISEASES|Tongue Neoplasms	CTD_CHEMICALS_DISEASES|Tooth Abnormalities	CTD_CHEMICALS_DISEASES|Tooth Agenesis, Selective, 4	CTD_CHEMICALS_DISEASES|Trigeminal Neuralgia	CTD_CHEMICALS_DISEASES|Unconsciousness	CTD_CHEMICALS_DISEASES|Uremia	CTD_CHEMICALS_DISEASES|Ureteral Calculi	CTD_CHEMICALS_DISEASES|Ureteral Neoplasms	CTD_CHEMICALS_DISEASES|Ureteral Obstruction	CTD_CHEMICALS_DISEASES|Urinary Bladder Calculi	CTD_CHEMICALS_DISEASES|Urinary Bladder Neck Obstruction	CTD_CHEMICALS_DISEASES|Urinary Bladder Neoplasms	CTD_CHEMICALS_DISEASES|Urinary Tract Infections	CTD_CHEMICALS_DISEASES|Urticaria	CTD_CHEMICALS_DISEASES|Uterine Cervical Neoplasms	CTD_CHEMICALS_DISEASES|VACTERL Association With Hydrocephalus	CTD_CHEMICALS_DISEASES|Varicose Veins	CTD_CHEMICALS_DISEASES|Vascular Diseases	CTD_CHEMICALS_DISEASES|Vascular System Injuries	CTD_CHEMICALS_DISEASES|Ventricular Dysfunction, Left	CTD_CHEMICALS_DISEASES|Ventricular Premature Complexes	CTD_CHEMICALS_DISEASES|Ventricular Remodeling	CTD_CHEMICALS_DISEASES|Vesico-Ureteral Reflux	CTD_CHEMICALS_DISEASES|Vitamin A Deficiency	CTD_CHEMICALS_DISEASES|Vitiligo	CTD_CHEMICALS_DISEASES|Vomiting	CTD_CHEMICALS_DISEASES|Walker-Warburg Syndrome	CTD_CHEMICALS_DISEASES|Warfarin Sensitivity	CTD_CHEMICALS_DISEASES|Weight Gain	CTD_CHEMICALS_DISEASES|Weight Loss	CTD_CHEMICALS_DISEASES|Wilms Tumor	CTD_CHEMICALS_DISEASES|Wounds and Injuries	CTD_CHEMICALS_DISEASES|Zellweger Syndrome	CTD_CHEMICALS_DISEASES|beta-Thalassemia	CTD_CHEMICALS_DISEASES|von Hippel-Lindau Disease	CTD_CHEMICALS_GENES|ACP2;AHR;AHRR;AR;ARNT;BAX;CASP3;CCNA2;CCND1;CDK2;COMT;CXCL8;CYP19A1;CYP1A1;CYP1A2;CYP1B1;ESR1;NFKB2;NR1I3;PTGS2;TNF	CTD_CHEMICALS_GENES|AHR;CXCL8;CYP1A;CYP1A2;CYP1B1;CYP2A13;CYP2A6;NR1I3;OPRK1	CTD_CHEMICALS_GENES|AHR;CYP1A1;CYP1A;NR1I3;CYP1A2;CAT;CXCL8;CYP1B1;CASP3;AR;CYP3A4;AHRR;SULT1A1;CYP2B10;IL4;ARNT;TRP53;TF;CCNA2;FADS2;UGT1A6;ESR1;COX3;FABP6;LOX	CTD_CHEMICALS_GENES|AHR;CYP1A1;CYP1B1;AIFM1;MKI67;CYP4B1;XRCC6;COL1A1;TMEM266;FUS;POLG;CLCA1;PPARGC1A;KCNK10;PREX2;C1QTNF2;PCNX2;GYG;GADD45B;C4B;CLIC4;SH3D21;CES2E;NUMB;TSPAN18	CTD_CHEMICALS_GENES|AHR;CYP1A1;CYP1B1;CYP1A2;TP53;NQO1;TNF;CDKN1A;CYP1A;CAT;NFE2L2;MDM2;IL1B;CASP3;MAPK3;TRP53;MAPK1;ESR1;BAX;BRCA1;PTGS2;BCL2;GSR;CXCL8;ALDH3A1	CTD_CHEMICALS_GENES|CYP1A1;AHR;CYP1A2;CYP1B1;EPHX1;NQO1;AKR1B1;AR;ID1;EHHADH;UGCG;SERPIND1;IGFBP1;HSD11B1;ACOX2;RRAD;SLC16A1;TUBB5;NUPR1;CLDN7;DUSP1;NUP58;CYP2B6;LBP;TSC22D3	CTD_CHEMICALS_GENES|CYP1A1;AHR;CYP1B1;CYP1A2;CYP1A;KLK3;EPHX1;AR;TRP53;AEN;C2CD3;FNDC1;KITL;SDF4;ABCC5;CES2E;IER5;MPEG1;MFAP1B;ZFP628;ABI3BP;PTMA;ASGR2;COL4A4;H13	CTD_CHEMICALS_GENES|CYP1A1;AHR;CYP1B1;TNF;CYP1A;CXCL8;AHR2;NOS3;PTGS2;GSTP2;IL6;GJA1;TRP53;AHRR;EGR1;NQO1;GJB1;ESR1;CYP1A2;TIPARP;AR;ID1;PTX3;GADD45G;FOS	CTD_CHEMICALS_GENES|CYP1A1;AHR;NR1I3;CYP1A2;AR;CYP1B1	CTD_CHEMICALS_GENES|CYP1A1;CYP1B1;AHR;TNF;TFF1;CYP1A2;IL6;NQO1;ESR1;GSTA2;CYP1A;EPHX1;AREG;MMP2;TRP53;ITGA2;CCNA2;PGR;PRL;MAPK14;CYP17A1;ACOX1;ETS1;CDKN1A;CXCL12	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0005623|cell;GO:0044464|cell part;GO:0044424|intracellular part;GO:0005622|intracellular;GO:0043226|organelle;GO:0005737|cytoplasm;GO:0043227|membrane-bounded organelle;GO:0043229|intracellular organelle;GO:0044444|cytoplasmic part;GO:0044422|organelle part;GO:0044446|intracellular organelle part;GO:0043231|intracellular membrane-bounded organelle;GO:0005634|nucleus;GO:0031974|membrane-enclosed lumen;GO:0043233|organelle lumen;GO:0070013|intracellular organelle lumen;GO:0016020|membrane;GO:0044425|membrane part;GO:0120025|plasma membrane bounded cell projection;GO:0005829|cytosol;GO:0044428|nuclear part;GO:0042995|cell projection;GO:0043005|neuron projection;GO:0012505|endomembrane system;GO:0031981|nuclear lumen;GO:0036477|somatodendritic compartment;GO:0005576|extracellular region;GO:0097458|neuron part;GO:0097447|dendritic tree;GO:0043232|intracellular non-membrane-bounded organelle;GO:0043228|non-membrane-bounded organelle;GO:0043025|neuronal cell body;GO:0044297|cell body;GO:0044459|plasma membrane part;GO:0030425|dendrite;GO:0044454|nuclear chromosome part;GO:0071944|cell periphery;GO:0005654|nucleoplasm;GO:0005886|plasma membrane;GO:0000228|nuclear chromosome;GO:0031982|vesicle;GO:0044463|cell projection part;GO:0120038|plasma membrane bounded cell projection part;GO:0031224|intrinsic component of membrane;GO:0098590|plasma membrane region;GO:0044427|chromosomal part;GO:0005694|chromosome;GO:0016021|integral component of membrane;GO:0044421|extracellular region part;GO:0000790|nuclear chromatin;GO:0045177|apical part of cell;GO:0044432|endoplasmic reticulum part;GO:0031410|cytoplasmic vesicle;GO:0097708|intracellular vesicle	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0005634|nucleus;GO:0031974|membrane-enclosed lumen;GO:0043233|organelle lumen;GO:0070013|intracellular organelle lumen;GO:0005654|nucleoplasm;GO:0071944|cell periphery;GO:0005829|cytosol;GO:0044428|nuclear part;GO:0005886|plasma membrane;GO:0031981|nuclear lumen;GO:0012505|endomembrane system;GO:0043228|non-membrane-bounded organelle;GO:0043232|intracellular non-membrane-bounded organelle;GO:0044425|membrane part;GO:0044459|plasma membrane part;GO:0005576|extracellular region;GO:0032991|protein-containing complex;GO:0031224|intrinsic component of membrane;GO:0031982|vesicle;GO:0016021|integral component of membrane;GO:0031410|cytoplasmic vesicle;GO:0097708|intracellular vesicle;GO:0005856|cytoskeleton;GO:0042995|cell projection;GO:0044421|extracellular region part;GO:0120025|plasma membrane bounded cell projection;GO:0016604|nuclear body;GO:0005783|endoplasmic reticulum;GO:0031090|organelle membrane;GO:0031226|intrinsic component of plasma membrane;GO:0044451|nucleoplasm part;GO:0016607|nuclear speck;GO:0005887|integral component of plasma membrane;GO:0044430|cytoskeletal part;GO:0005615|extracellular space;GO:0098590|plasma membrane region;GO:0098805|whole membrane;GO:0044432|endoplasmic reticulum part;GO:0030054|cell junction;GO:0098588|bounding membrane of organelle;GO:0005694|chromosome;GO:0031012|extracellular matrix;GO:0009986|cell surface;GO:0044463|cell projection part;GO:0120038|plasma membrane bounded cell projection part;GO:0097458|neuron part;GO:0031984|organelle subcompartment;GO:0044433|cytoplasmic vesicle part;GO:0062023|collagen-containing extracellular matrix;GO:0098552|side of membrane;GO:0015630|microtubule cytoskeleton;GO:0099081|supramolecular polymer;GO:0099080|supramolecular complex;GO:0048471|perinuclear region of cytoplasm;GO:0030141|secretory granule;GO:0099512|supramolecular fiber;GO:0043005|neuron projection;GO:0099503|secretory vesicle;GO:0044427|chromosomal part;GO:0045202|synapse;GO:0009897|external side of plasma membrane;GO:0098827|endoplasmic reticulum subcompartment;GO:0005794|Golgi apparatus;GO:0042175|nuclear outer membrane-endoplasmic reticulum membrane network;GO:0044420|extracellular matrix component;GO:0005789|endoplasmic reticulum membrane;GO:0000228|nuclear chromosome;GO:0098794|postsynapse;GO:0000785|chromatin;GO:0005635|nuclear envelope;GO:0005773|vacuole;GO:0005911|cell-cell junction;GO:0005815|microtubule organizing center;GO:0000790|nuclear chromatin;GO:0005764|lysosome;GO:0000323|lytic vacuole;GO:0044454|nuclear chromosome part;GO:0031967|organelle envelope;GO:0031975|envelope;GO:1902494|catalytic complex;GO:0005788|endoplasmic reticulum lumen;GO:0031252|cell leading edge;GO:0001726|ruffle;GO:0044456|synapse part;GO:0005813|centrosome;GO:0005730|nucleolus;GO:0036477|somatodendritic compartment;GO:0005739|mitochondrion;GO:0031983|vesicle lumen;GO:0005768|endosome;GO:0015629|actin cytoskeleton;GO:0043230|extracellular organelle;GO:0060205|cytoplasmic vesicle lumen;GO:0045121|membrane raft;GO:0098857|membrane microdomain;GO:0034774|secretory granule lumen;GO:0005938|cell cortex;GO:0099568|cytoplasmic region;GO:0042025|host cell nucleus;GO:0044431|Golgi apparatus part	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0005737|cytoplasm;GO:0044444|cytoplasmic part;GO:0043227|membrane-bounded organelle;GO:0043229|intracellular organelle;GO:0043231|intracellular membrane-bounded organelle;GO:0043226|organelle;GO:0044446|intracellular organelle part;GO:0044424|intracellular part;GO:0005622|intracellular;GO:0044422|organelle part;GO:0005623|cell;GO:0044464|cell part;GO:0044428|nuclear part;GO:0005654|nucleoplasm;GO:0005829|cytosol;GO:0031974|membrane-enclosed lumen;GO:0043233|organelle lumen;GO:0070013|intracellular organelle lumen;GO:0005634|nucleus;GO:0032991|protein-containing complex	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0005737|cytoplasm;GO:0044444|cytoplasmic part;GO:0044424|intracellular part;GO:0005622|intracellular;GO:0043226|organelle;GO:0043227|membrane-bounded organelle;GO:0005623|cell;GO:0044464|cell part;GO:0044422|organelle part;GO:0043231|intracellular membrane-bounded organelle;GO:0043229|intracellular organelle;GO:0044446|intracellular organelle part;GO:0012505|endomembrane system;GO:0031974|membrane-enclosed lumen;GO:0043233|organelle lumen;GO:0070013|intracellular organelle lumen;GO:0005829|cytosol;GO:0005783|endoplasmic reticulum;GO:0032991|protein-containing complex;GO:0044432|endoplasmic reticulum part;GO:0042175|nuclear outer membrane-endoplasmic reticulum membrane network;GO:0005634|nucleus;GO:0005789|endoplasmic reticulum membrane;GO:0098827|endoplasmic reticulum subcompartment;GO:0016020|membrane;GO:0044428|nuclear part;GO:0005654|nucleoplasm;GO:0031984|organelle subcompartment;GO:0044425|membrane part;GO:0031981|nuclear lumen;GO:0005739|mitochondrion;GO:0005576|extracellular region;GO:0044421|extracellular region part;GO:0005694|chromosome;GO:0031967|organelle envelope;GO:0031975|envelope;GO:0098805|whole membrane;GO:0043232|intracellular non-membrane-bounded organelle;GO:0043228|non-membrane-bounded organelle;GO:0031982|vesicle;GO:0044427|chromosomal part;GO:0044454|nuclear chromosome part;GO:0044429|mitochondrial part;GO:0000228|nuclear chromosome;GO:0005615|extracellular space;GO:0044459|plasma membrane part	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0030424|axon;GO:0098794|postsynapse;GO:0044297|cell body;GO:0030425|dendrite;GO:0097447|dendritic tree;GO:0015629|actin cytoskeleton;GO:0000139|Golgi membrane;GO:0043025|neuronal cell body;GO:0005773|vacuole;GO:0005911|cell-cell junction;GO:0005764|lysosome;GO:0000323|lytic vacuole;GO:0045177|apical part of cell;GO:1990234|transferase complex;GO:0098793|presynapse;GO:0031252|cell leading edge;GO:0005813|centrosome;GO:0005740|mitochondrial envelope;GO:0098552|side of membrane;GO:0033267|axon part;GO:0044440|endosomal part;GO:0031966|mitochondrial membrane;GO:0031983|vesicle lumen;GO:0099568|cytoplasmic region;GO:0060205|cytoplasmic vesicle lumen;GO:1990904|ribonucleoprotein complex;GO:0098857|membrane microdomain;GO:0010008|endosome membrane;GO:0098978|glutamatergic synapse;GO:0045121|membrane raft;GO:0098589|membrane region;GO:0005635|nuclear envelope;GO:0005788|endoplasmic reticulum lumen;GO:0034774|secretory granule lumen;GO:0070161|anchoring junction;GO:0031012|extracellular matrix;GO:0016324|apical plasma membrane;GO:0044437|vacuolar part;GO:0005912|adherens junction;GO:0031253|cell projection membrane;GO:0098984|neuron to neuron synapse;GO:0099572|postsynaptic specialization;GO:0005759|mitochondrial matrix;GO:0030139|endocytic vesicle;GO:0097060|synaptic membrane;GO:0150034|distal axon;GO:0099513|polymeric cytoskeletal fiber;GO:0016607|nuclear speck;GO:0032279|asymmetric synapse;GO:0005819|spindle;GO:0009897|external side of plasma membrane;GO:0005769|early endosome;GO:0014069|postsynaptic density;GO:0016323|basolateral plasma membrane;GO:0005929|cilium;GO:0005938|cell cortex;GO:0005874|microtubule;GO:0098797|plasma membrane protein complex;GO:0098858|actin-based cell projection;GO:0030133|transport vesicle;GO:0043292|contractile fiber;GO:0044441|ciliary part;GO:0031965|nuclear membrane;GO:0098687|chromosomal region;GO:0044449|contractile fiber part;GO:0062023|collagen-containing extracellular matrix;GO:0019866|organelle inner membrane;GO:0030016|myofibril;GO:0030027|lamellipodium;GO:0030667|secretory granule membrane;GO:0030135|coated vesicle;GO:0005667|transcription factor complex;GO:0030055|cell-substrate junction;GO:0044217|other organism part;GO:0044215|other organism;GO:0044216|other organism cell;GO:0030426|growth cone;GO:0044450|microtubule organizing center part;GO:0030017|sarcomere;GO:0005743|mitochondrial inner membrane;GO:0030427|site of polarized growth;GO:0018995|host;GO:0043657|host cell;GO:0005924|cell-substrate adherens junction;GO:1990351|transporter complex;GO:0005925|focal adhesion;GO:0005774|vacuolar membrane;GO:1902495|transmembrane transporter complex;GO:0005770|late endosome;GO:0101002|ficolin-1-rich granule;GO:0045211|postsynaptic membrane;GO:0019867|outer membrane;GO:0031968|organelle outer membrane;GO:0044309|neuron spine;GO:0031256|leading edge membrane;GO:0043197|dendritic spine;GO:0005775|vacuolar lumen;GO:0034702|ion channel complex;GO:0035770|ribonucleoprotein granule;GO:0019898|extrinsic component of membrane	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0031974|membrane-enclosed lumen;GO:0043233|organelle lumen;GO:0070013|intracellular organelle lumen;GO:0005634|nucleus;GO:0044428|nuclear part;GO:0005654|nucleoplasm;GO:0031981|nuclear lumen;GO:0012505|endomembrane system;GO:0005829|cytosol;GO:0016020|membrane;GO:0043232|intracellular non-membrane-bounded organelle;GO:0043228|non-membrane-bounded organelle;GO:0044425|membrane part;GO:0031090|organelle membrane;GO:0032991|protein-containing complex;GO:0005783|endoplasmic reticulum;GO:0031984|organelle subcompartment;GO:0044427|chromosomal part;GO:0044432|endoplasmic reticulum part;GO:0005694|chromosome;GO:0000228|nuclear chromosome;GO:0000785|chromatin;GO:0000790|nuclear chromatin;GO:0031982|vesicle;GO:0031410|cytoplasmic vesicle;GO:0005739|mitochondrion;GO:0097708|intracellular vesicle;GO:0044454|nuclear chromosome part;GO:0042175|nuclear outer membrane-endoplasmic reticulum membrane network;GO:0005789|endoplasmic reticulum membrane;GO:0098827|endoplasmic reticulum subcompartment;GO:0071944|cell periphery;GO:0098588|bounding membrane of organelle;GO:0005886|plasma membrane;GO:0031967|organelle envelope;GO:0031975|envelope;GO:0098805|whole membrane;GO:0005794|Golgi apparatus;GO:0031224|intrinsic component of membrane;GO:0016021|integral component of membrane;GO:0044429|mitochondrial part;GO:0005576|extracellular region;GO:0044433|cytoplasmic vesicle part;GO:0005740|mitochondrial envelope;GO:0044459|plasma membrane part;GO:0005730|nucleolus;GO:0005856|cytoskeleton;GO:0031966|mitochondrial membrane;GO:0043656|intracellular region of host;GO:0033646|host intracellular part;GO:0033643|host cell part;GO:0018995|host;GO:0043657|host cell;GO:0044217|other organism part;GO:0044215|other organism;GO:0044216|other organism cell;GO:0016604|nuclear body;GO:0042025|host cell nucleus;GO:0033648|host intracellular membrane-bounded organelle;GO:0033647|host intracellular organelle;GO:0044431|Golgi apparatus part;GO:0019866|organelle inner membrane;GO:0044451|nucleoplasm part;GO:0005615|extracellular space;GO:0044421|extracellular region part;GO:0005667|transcription factor complex;GO:0098791|Golgi subcompartment;GO:0098590|plasma membrane region;GO:0005743|mitochondrial inner membrane;GO:0015630|microtubule cytoskeleton;GO:0005768|endosome;GO:0042995|cell projection;GO:0120025|plasma membrane bounded cell projection;GO:0000139|Golgi membrane;GO:0097458|neuron part;GO:0016607|nuclear speck;GO:0042579|microbody;GO:0005777|peroxisome;GO:0044430|cytoskeletal part;GO:0005635|nuclear envelope;GO:0048471|perinuclear region of cytoplasm;GO:0044798|nuclear transcription factor complex;GO:0043005|neuron projection;GO:0005815|microtubule organizing center;GO:0045121|membrane raft;GO:0098857|membrane microdomain;GO:0005773|vacuole;GO:0098589|membrane region;GO:0099503|secretory vesicle;GO:0030054|cell junction;GO:0030141|secretory granule;GO:0005813|centrosome;GO:0090575|RNA polymerase II transcription factor complex;GO:1902494|catalytic complex;GO:0044853|plasma membrane raft;GO:0036477|somatodendritic compartment;GO:0044438|microbody part;GO:0044439|peroxisomal part;GO:0044463|cell projection part;GO:0120038|plasma membrane bounded cell projection part	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0044444|cytoplasmic part;GO:0005737|cytoplasm;GO:0005623|cell;GO:0044464|cell part;GO:0044424|intracellular part;GO:0005622|intracellular;GO:0043227|membrane-bounded organelle;GO:0043226|organelle;GO:0043229|intracellular organelle;GO:0043231|intracellular membrane-bounded organelle;GO:0044422|organelle part;GO:0044446|intracellular organelle part;GO:0012505|endomembrane system;GO:0044432|endoplasmic reticulum part;GO:0016020|membrane;GO:0005783|endoplasmic reticulum;GO:0044425|membrane part;GO:0005789|endoplasmic reticulum membrane;GO:0098827|endoplasmic reticulum subcompartment;GO:0042175|nuclear outer membrane-endoplasmic reticulum membrane network;GO:0005829|cytosol;GO:0031982|vesicle;GO:0031410|cytoplasmic vesicle;GO:0097708|intracellular vesicle;GO:0031984|organelle subcompartment;GO:0005576|extracellular region;GO:0031974|membrane-enclosed lumen;GO:0043233|organelle lumen;GO:0070013|intracellular organelle lumen;GO:0031224|intrinsic component of membrane;GO:0044421|extracellular region part;GO:0071944|cell periphery;GO:0032991|protein-containing complex;GO:0044459|plasma membrane part;GO:0005615|extracellular space;GO:1904813|ficolin-1-rich granule lumen;GO:1903561|extracellular vesicle;GO:0005886|plasma membrane;GO:0043230|extracellular organelle;GO:0016021|integral component of membrane;GO:0070062|extracellular exosome;GO:0101002|ficolin-1-rich granule;GO:0030141|secretory granule;GO:0099503|secretory vesicle;GO:0044433|cytoplasmic vesicle part;GO:0031090|organelle membrane;GO:0005654|nucleoplasm;GO:0005634|nucleus;GO:0060205|cytoplasmic vesicle lumen;GO:0031983|vesicle lumen;GO:0031226|intrinsic component of plasma membrane;GO:0018995|host;GO:0043657|host cell;GO:0044217|other organism part;GO:0044215|other organism;GO:0044216|other organism cell;GO:0005739|mitochondrion;GO:0034774|secretory granule lumen;GO:0098805|whole membrane;GO:0031967|organelle envelope;GO:0031975|envelope;GO:0005768|endosome;GO:0044428|nuclear part;GO:0043232|intracellular non-membrane-bounded organelle;GO:0043228|non-membrane-bounded organelle;GO:0005887|integral component of plasma membrane;GO:0031981|nuclear lumen;GO:0098590|plasma membrane region;GO:0005740|mitochondrial envelope	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0044444|cytoplasmic part;GO:0044422|organelle part;GO:0044446|intracellular organelle part;GO:0005634|nucleus;GO:0016020|membrane;GO:0031974|membrane-enclosed lumen;GO:0043233|organelle lumen;GO:0070013|intracellular organelle lumen;GO:0044428|nuclear part;GO:0005654|nucleoplasm;GO:0031981|nuclear lumen;GO:0005829|cytosol;GO:0071944|cell periphery;GO:0005886|plasma membrane;GO:0043228|non-membrane-bounded organelle;GO:0043232|intracellular non-membrane-bounded organelle;GO:0012505|endomembrane system;GO:0044425|membrane part;GO:0032991|protein-containing complex;GO:0044459|plasma membrane part;GO:0031224|intrinsic component of membrane;GO:0016021|integral component of membrane;GO:0005783|endoplasmic reticulum;GO:0005576|extracellular region;GO:0005856|cytoskeleton;GO:0044421|extracellular region part;GO:0044432|endoplasmic reticulum part;GO:0031982|vesicle;GO:0016604|nuclear body;GO:0031012|extracellular matrix;GO:0044451|nucleoplasm part;GO:0031090|organelle membrane;GO:0031226|intrinsic component of plasma membrane;GO:0062023|collagen-containing extracellular matrix;GO:0005887|integral component of plasma membrane;GO:0031984|organelle subcompartment;GO:0044430|cytoskeletal part;GO:0031410|cytoplasmic vesicle;GO:0097708|intracellular vesicle;GO:0042995|cell projection;GO:0120025|plasma membrane bounded cell projection;GO:0098827|endoplasmic reticulum subcompartment;GO:0042175|nuclear outer membrane-endoplasmic reticulum membrane network;GO:0005789|endoplasmic reticulum membrane;GO:0098588|bounding membrane of organelle;GO:0098805|whole membrane;GO:0009986|cell surface;GO:0016607|nuclear speck;GO:0030054|cell junction;GO:0044420|extracellular matrix component;GO:0005615|extracellular space;GO:0097458|neuron part;GO:0045202|synapse;GO:0099081|supramolecular polymer;GO:0099080|supramolecular complex;GO:0044433|cytoplasmic vesicle part;GO:0099512|supramolecular fiber;GO:0005694|chromosome;GO:0015630|microtubule cytoskeleton;GO:0099503|secretory vesicle;GO:0015629|actin cytoskeleton;GO:0098590|plasma membrane region;GO:0005794|Golgi apparatus;GO:0030141|secretory granule;GO:0005938|cell cortex;GO:0098794|postsynapse;GO:0043005|neuron projection;GO:0044456|synapse part;GO:0036477|somatodendritic compartment;GO:0000228|nuclear chromosome;GO:0005815|microtubule organizing center;GO:0009897|external side of plasma membrane;GO:0044427|chromosomal part;GO:0043292|contractile fiber;GO:0005604|basement membrane;GO:0098552|side of membrane;GO:0005813|centrosome;GO:0000785|chromatin;GO:1902494|catalytic complex;GO:0098796|membrane protein complex;GO:0044449|contractile fiber part;GO:0099568|cytoplasmic region;GO:0044431|Golgi apparatus part;GO:0030016|myofibril;GO:0030175|filopodium;GO:0044463|cell projection part;GO:0120038|plasma membrane bounded cell projection part;GO:0048471|perinuclear region of cytoplasm;GO:0044448|cell cortex part;GO:0070161|anchoring junction;GO:0098589|membrane region;GO:0044454|nuclear chromosome part;GO:0005912|adherens junction;GO:0030017|sarcomere;GO:0005581|collagen trimer;GO:0045121|membrane raft;GO:0005635|nuclear envelope;GO:0098857|membrane microdomain;GO:0005730|nucleolus;GO:0000790|nuclear chromatin	CTD_CHEMICALS_GOENRICH_CELLCOMP|GO:0044444|cytoplasmic part;GO:0044422|organelle part;GO:0044446|intracellular organelle part;GO:0043231|intracellular membrane-bounded organelle;GO:0016020|membrane;GO:0071944|cell periphery;GO:0005886|plasma membrane;GO:0005829|cytosol;GO:0044425|membrane part;GO:0012505|endomembrane system;GO:0005634|nucleus;GO:0031974|membrane-enclosed lumen;GO:0043233|organelle lumen;GO:0070013|intracellular organelle lumen;GO:0005576|extracellular region;GO:0043228|non-membrane-bounded organelle;GO:0043232|intracellular non-membrane-bounded organelle;GO:0031224|intrinsic component of membrane;GO:0044459|plasma membrane part;GO:0016021|integral component of membrane;GO:0044421|extracellular region part;GO:0044428|nuclear part;GO:0005654|nucleoplasm;GO:0005783|endoplasmic reticulum;GO:0031981|nuclear lumen;GO:0005856|cytoskeleton;GO:0031982|vesicle;GO:0031226|intrinsic component of plasma membrane;GO:0044432|endoplasmic reticulum part;GO:0005615|extracellular space;GO:0005887|integral component of plasma membrane;GO:0031410|cytoplasmic vesicle;GO:0097708|intracellular vesicle;GO:0044427|chromosomal part;GO:0005694|chromosome;GO:0044430|cytoskeletal part;GO:0032991|protein-containing complex;GO:0030054|cell junction;GO:0015630|microtubule cytoskeleton;GO:0098590|plasma membrane region;GO:0009986|cell surface;GO:0031091|platelet alpha granule;GO:0000785|chromatin;GO:0048471|perinuclear region of cytoplasm;GO:0000228|nuclear chromosome;GO:0031090|organelle membrane;GO:0042995|cell projection;GO:0030141|secretory granule;GO:0031093|platelet alpha granule lumen;GO:0120025|plasma membrane bounded cell projection;GO:0044454|nuclear chromosome part;GO:0005813|centrosome;GO:0036477|somatodendritic compartment;GO:0097458|neuron part;GO:0043025|neuronal cell body;GO:0031984|organelle subcompartment;GO:0045177|apical part of cell;GO:0042175|nuclear outer membrane-endoplasmic reticulum membrane network;GO:0099503|secretory vesicle;GO:0098827|endoplasmic reticulum subcompartment;GO:0044433|cytoplasmic vesicle part;GO:0005815|microtubule organizing center;GO:0031012|extracellular matrix;GO:0016324|apical plasma membrane;GO:0000790|nuclear chromatin;GO:0005789|endoplasmic reticulum membrane;GO:0098805|whole membrane;GO:0044297|cell body;GO:0043005|neuron projection;GO:0062023|collagen-containing extracellular matrix;GO:0098588|bounding membrane of organelle;GO:0005788|endoplasmic reticulum lumen;GO:0005819|spindle;GO:0044463|cell projection part;GO:0120038|plasma membrane bounded cell projection part;GO:0060205|cytoplasmic vesicle lumen;GO:0031983|vesicle lumen;GO:0034774|secretory granule lumen;GO:0005794|Golgi apparatus;GO:0030496|midbody;GO:0005911|cell-cell junction;GO:0099081|supramolecular polymer;GO:0099080|supramolecular complex;GO:0000793|condensed chromosome;GO:0016323|basolateral plasma membrane;GO:0045202|synapse;GO:0099512|supramolecular fiber;GO:0070161|anchoring junction;GO:0043230|extracellular organelle;GO:0044438|microbody part;GO:0044439|peroxisomal part;GO:0000922|spindle pole;GO:0005604|basement membrane;GO:0005739|mitochondrion;GO:1903561|extracellular vesicle;GO:0043656|intracellular region of host;GO:0033646|host intracellular part;GO:0033643|host cell part;GO:0000779|condensed chromosome, centromeric region;GO:0005912|adherens junction	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0005488|binding;GO:0005515|protein binding;GO:0003824|catalytic activity;GO:0016491|oxidoreductase activity;GO:0043167|ion binding;GO:0042802|identical protein binding;GO:0048037|cofactor binding;GO:0016705|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;GO:0005506|iron ion binding;GO:0046914|transition metal ion binding;GO:0043169|cation binding;GO:0020037|heme binding;GO:0004497|monooxygenase activity;GO:0046906|tetrapyrrole binding;GO:0046872|metal ion binding;GO:0019899|enzyme binding;GO:0042803|protein homodimerization activity;GO:0008289|lipid binding;GO:0005102|signaling receptor binding;GO:0046983|protein dimerization activity;GO:0036094|small molecule binding;GO:0097159|organic cyclic compound binding;GO:0033218|amide binding;GO:1901363|heterocyclic compound binding;GO:0043168|anion binding;GO:0016740|transferase activity;GO:0008144|drug binding	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0005488|binding;GO:0005515|protein binding;GO:0003824|catalytic activity;GO:0048037|cofactor binding;GO:0016491|oxidoreductase activity;GO:0042802|identical protein binding;GO:0043167|ion binding;GO:0097159|organic cyclic compound binding;GO:0046914|transition metal ion binding;GO:1901363|heterocyclic compound binding;GO:0019899|enzyme binding;GO:0004497|monooxygenase activity;GO:0016705|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;GO:0020037|heme binding;GO:0046906|tetrapyrrole binding;GO:0046983|protein dimerization activity;GO:0046872|metal ion binding;GO:0043169|cation binding;GO:0036094|small molecule binding;GO:0140110|transcription regulator activity;GO:0005506|iron ion binding;GO:0000976|transcription regulatory region sequence-specific DNA binding;GO:0044212|transcription regulatory region DNA binding;GO:0001067|regulatory region nucleic acid binding;GO:0042803|protein homodimerization activity;GO:1990837|sequence-specific double-stranded DNA binding;GO:0005102|signaling receptor binding;GO:0008144|drug binding;GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding;GO:0001012|RNA polymerase II regulatory region DNA binding;GO:0003690|double-stranded DNA binding;GO:0050662|coenzyme binding;GO:0008134|transcription factor binding;GO:0043565|sequence-specific DNA binding;GO:0003700|DNA-binding transcription factor activity;GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0043168|anion binding;GO:0008270|zinc ion binding;GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding;GO:0003677|DNA binding;GO:0016740|transferase activity;GO:0000987|proximal promoter sequence-specific DNA binding;GO:0003712|transcription coregulator activity	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0005488|binding;GO:0005515|protein binding;GO:0043167|ion binding;GO:0097159|organic cyclic compound binding;GO:1901363|heterocyclic compound binding;GO:0046872|metal ion binding;GO:0003824|catalytic activity;GO:0043169|cation binding;GO:0042802|identical protein binding;GO:0036094|small molecule binding;GO:0019899|enzyme binding;GO:0048037|cofactor binding;GO:0008092|cytoskeletal protein binding;GO:0098772|molecular function regulator;GO:0003677|DNA binding;GO:0043168|anion binding	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0005488|binding;GO:1901363|heterocyclic compound binding;GO:0097159|organic cyclic compound binding;GO:0005515|protein binding	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0042803|protein homodimerization activity;GO:0016773|phosphotransferase activity, alcohol group as acceptor;GO:0008134|transcription factor binding;GO:0019901|protein kinase binding;GO:0048037|cofactor binding;GO:0016462|pyrophosphatase activity;GO:0016817|hydrolase activity, acting on acid anhydrides;GO:0016818|hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;GO:0005509|calcium ion binding;GO:0015318|inorganic molecular entity transmembrane transporter activity;GO:0004672|protein kinase activity;GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding;GO:0001012|RNA polymerase II regulatory region DNA binding;GO:0017111|nucleoside-triphosphatase activity;GO:0016788|hydrolase activity, acting on ester bonds;GO:0000987|proximal promoter sequence-specific DNA binding;GO:0005198|structural molecule activity;GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding;GO:0008324|cation transmembrane transporter activity;GO:0003712|transcription coregulator activity;GO:0003779|actin binding;GO:0004674|protein serine/threonine kinase activity;GO:0008047|enzyme activator activity;GO:0005543|phospholipid binding;GO:0022890|inorganic cation transmembrane transporter activity;GO:0051020|GTPase binding;GO:0003682|chromatin binding;GO:0008233|peptidase activity;GO:0050662|coenzyme binding;GO:0030545|receptor regulator activity;GO:0070011|peptidase activity, acting on L-amino acid peptides;GO:0046873|metal ion transmembrane transporter activity;GO:0044389|ubiquitin-like protein ligase binding;GO:0022804|active transmembrane transporter activity;GO:0004857|enzyme inhibitor activity;GO:0042578|phosphoric ester hydrolase activity;GO:0048018|receptor ligand activity;GO:1901681|sulfur compound binding;GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific;GO:0008509|anion transmembrane transporter activity;GO:0031625|ubiquitin protein ligase binding;GO:0031267|small GTPase binding;GO:0046982|protein heterodimerization activity;GO:0050839|cell adhesion molecule binding;GO:0033218|amide binding;GO:0017016|Ras GTPase binding;GO:0015291|secondary active transmembrane transporter activity;GO:0060589|nucleoside-triphosphatase regulator activity;GO:0005539|glycosaminoglycan binding;GO:0022803|passive transmembrane transporter activity;GO:0015267|channel activity;GO:0003713|transcription coactivator activity;GO:0032561|guanyl ribonucleotide binding;GO:0019001|guanyl nucleotide binding;GO:0008514|organic anion transmembrane transporter activity;GO:0019787|ubiquitin-like protein transferase activity;GO:0005201|extracellular matrix structural constituent;GO:0022838|substrate-specific channel activity;GO:0001882|nucleoside binding;GO:0032549|ribonucleoside binding;GO:0001883|purine nucleoside binding;GO:0016757|transferase activity, transferring glycosyl groups;GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0004842|ubiquitin-protein transferase activity;GO:0032550|purine ribonucleoside binding;GO:0016791|phosphatase activity;GO:0005126|cytokine receptor binding;GO:0015077|monovalent inorganic cation transmembrane transporter activity;GO:0005216|ion channel activity;GO:0030695|GTPase regulator activity;GO:0000287|magnesium ion binding;GO:0043177|organic acid binding;GO:0005525|GTP binding;GO:0016887|ATPase activity;GO:0019902|phosphatase binding;GO:0031406|carboxylic acid binding;GO:0042277|peptide binding;GO:0005516|calmodulin binding;GO:0008201|heparin binding;GO:0061134|peptidase regulator activity;GO:0035091|phosphatidylinositol binding;GO:0005096|GTPase activator activity;GO:0004175|endopeptidase activity;GO:0015293|symporter activity;GO:0005261|cation channel activity;GO:0019838|growth factor binding;GO:0001664|G protein-coupled receptor binding;GO:0015631|tubulin binding;GO:0030246|carbohydrate binding;GO:0008022|protein C-terminus binding;GO:0003714|transcription corepressor activity;GO:0019842|vitamin binding;GO:0051427|hormone receptor binding;GO:0046906|tetrapyrrole binding;GO:0004721|phosphoprotein phosphatase activity;GO:0005342|organic acid transmembrane transporter activity;GO:0019903|protein phosphatase binding;GO:0140097|catalytic activity, acting on DNA;GO:0005178|integrin binding;GO:0046943|carboxylic acid transmembrane transporter activity	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0043167|ion binding;GO:0003824|catalytic activity;GO:0042802|identical protein binding;GO:0043168|anion binding;GO:0005102|signaling receptor binding;GO:0019899|enzyme binding;GO:0097159|organic cyclic compound binding;GO:1901363|heterocyclic compound binding;GO:0036094|small molecule binding;GO:0098772|molecular function regulator;GO:0043169|cation binding;GO:0046872|metal ion binding;GO:0044877|protein-containing complex binding;GO:0000166|nucleotide binding;GO:1901265|nucleoside phosphate binding;GO:0097367|carbohydrate derivative binding;GO:0046983|protein dimerization activity;GO:0008144|drug binding;GO:0003690|double-stranded DNA binding;GO:0016491|oxidoreductase activity;GO:0030554|adenyl nucleotide binding;GO:0042803|protein homodimerization activity;GO:0017076|purine nucleotide binding;GO:0032559|adenyl ribonucleotide binding;GO:0032553|ribonucleotide binding;GO:0016740|transferase activity;GO:0032555|purine ribonucleotide binding;GO:0019904|protein domain specific binding;GO:0005524|ATP binding;GO:0019900|kinase binding;GO:0035639|purine ribonucleoside triphosphate binding;GO:0019838|growth factor binding;GO:0044212|transcription regulatory region DNA binding;GO:0001067|regulatory region nucleic acid binding;GO:0043565|sequence-specific DNA binding;GO:0003677|DNA binding;GO:1990837|sequence-specific double-stranded DNA binding;GO:0000976|transcription regulatory region sequence-specific DNA binding;GO:0046914|transition metal ion binding;GO:0008289|lipid binding;GO:0005201|extracellular matrix structural constituent;GO:0050839|cell adhesion molecule binding;GO:0030234|enzyme regulator activity;GO:0016787|hydrolase activity;GO:0140110|transcription regulator activity;GO:0004497|monooxygenase activity;GO:0140096|catalytic activity, acting on a protein;GO:0048037|cofactor binding;GO:0050661|NADP binding;GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0003700|DNA-binding transcription factor activity;GO:0008134|transcription factor binding;GO:0005520|insulin-like growth factor binding;GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding;GO:0001012|RNA polymerase II regulatory region DNA binding;GO:0016301|kinase activity;GO:0016773|phosphotransferase activity, alcohol group as acceptor;GO:0019901|protein kinase binding;GO:0048018|receptor ligand activity;GO:0000987|proximal promoter sequence-specific DNA binding;GO:0016772|transferase activity, transferring phosphorus-containing groups;GO:0030545|receptor regulator activity;GO:0016705|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;GO:0003682|chromatin binding;GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding;GO:0046982|protein heterodimerization activity;GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific;GO:0005215|transporter activity;GO:0008092|cytoskeletal protein binding;GO:0005178|integrin binding;GO:0008083|growth factor activity;GO:0005506|iron ion binding;GO:0003676|nucleic acid binding;GO:0016709|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;GO:0004672|protein kinase activity;GO:0022857|transmembrane transporter activity;GO:0005509|calcium ion binding;GO:0005198|structural molecule activity;GO:0044389|ubiquitin-like protein ligase binding;GO:0008270|zinc ion binding;GO:0031072|heat shock protein binding;GO:0050662|coenzyme binding;GO:0050660|flavin adenine dinucleotide binding;GO:0005539|glycosaminoglycan binding;GO:0008047|enzyme activator activity;GO:0061134|peptidase regulator activity;GO:0020037|heme binding;GO:0005543|phospholipid binding;GO:0004857|enzyme inhibitor activity;GO:0031625|ubiquitin protein ligase binding;GO:0003714|transcription corepressor activity;GO:0046906|tetrapyrrole binding;GO:0042562|hormone binding;GO:0005319|lipid transporter activity;GO:0001664|G protein-coupled receptor binding;GO:0008022|protein C-terminus binding;GO:0022804|active transmembrane transporter activity;GO:0005126|cytokine receptor binding;GO:0033218|amide binding	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0043167|ion binding;GO:0003824|catalytic activity;GO:0097159|organic cyclic compound binding;GO:1901363|heterocyclic compound binding;GO:0019899|enzyme binding;GO:0140110|transcription regulator activity;GO:0003690|double-stranded DNA binding;GO:0043169|cation binding;GO:1990837|sequence-specific double-stranded DNA binding;GO:0044212|transcription regulatory region DNA binding;GO:0003700|DNA-binding transcription factor activity;GO:0001067|regulatory region nucleic acid binding;GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0000976|transcription regulatory region sequence-specific DNA binding;GO:0046872|metal ion binding;GO:0043565|sequence-specific DNA binding;GO:0042802|identical protein binding;GO:0043168|anion binding;GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding;GO:0001012|RNA polymerase II regulatory region DNA binding;GO:0036094|small molecule binding;GO:0003677|DNA binding;GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific;GO:0008134|transcription factor binding;GO:0016491|oxidoreductase activity;GO:0003676|nucleic acid binding;GO:0000987|proximal promoter sequence-specific DNA binding;GO:0046914|transition metal ion binding;GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding;GO:0019900|kinase binding;GO:0005102|signaling receptor binding;GO:0000166|nucleotide binding;GO:1901265|nucleoside phosphate binding;GO:0140096|catalytic activity, acting on a protein;GO:0098772|molecular function regulator;GO:0097367|carbohydrate derivative binding;GO:0008270|zinc ion binding;GO:0016740|transferase activity;GO:0019901|protein kinase binding;GO:0003712|transcription coregulator activity;GO:0046983|protein dimerization activity;GO:0032553|ribonucleotide binding;GO:0016787|hydrolase activity;GO:0032555|purine ribonucleotide binding;GO:0017076|purine nucleotide binding;GO:0008144|drug binding;GO:0019904|protein domain specific binding;GO:0042803|protein homodimerization activity;GO:0035639|purine ribonucleoside triphosphate binding;GO:0032559|adenyl ribonucleotide binding;GO:0030554|adenyl nucleotide binding;GO:0003682|chromatin binding;GO:0098531|transcription factor activity, direct ligand regulated sequence-specific DNA binding;GO:0004879|nuclear receptor activity;GO:0005524|ATP binding;GO:0048037|cofactor binding;GO:0044389|ubiquitin-like protein ligase binding;GO:0044877|protein-containing complex binding;GO:0001227|DNA-binding transcription repressor activity, RNA polymerase II-specific;GO:0003714|transcription corepressor activity;GO:0046332|SMAD binding;GO:0031625|ubiquitin protein ligase binding;GO:0030234|enzyme regulator activity;GO:0001085|RNA polymerase II transcription factor binding;GO:0030545|receptor regulator activity;GO:0016772|transferase activity, transferring phosphorus-containing groups;GO:0016614|oxidoreductase activity, acting on CH-OH group of donors;GO:0016616|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;GO:0048018|receptor ligand activity;GO:0008083|growth factor activity;GO:0001221|transcription cofactor binding;GO:0003707|steroid hormone receptor activity;GO:0050662|coenzyme binding;GO:0016301|kinase activity;GO:0016773|phosphotransferase activity, alcohol group as acceptor;GO:0031072|heat shock protein binding;GO:0008289|lipid binding;GO:0005215|transporter activity;GO:0019207|kinase regulator activity;GO:0009055|electron transfer activity;GO:0003713|transcription coactivator activity;GO:0008013|beta-catenin binding;GO:0016705|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;GO:0033613|activating transcription factor binding;GO:0008233|peptidase activity;GO:0070011|peptidase activity, acting on L-amino acid peptides;GO:0046982|protein heterodimerization activity;GO:0042826|histone deacetylase binding;GO:0004672|protein kinase activity;GO:0005126|cytokine receptor binding	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0043167|ion binding;GO:0097159|organic cyclic compound binding;GO:1901363|heterocyclic compound binding;GO:0003824|catalytic activity;GO:0019899|enzyme binding;GO:0043169|cation binding;GO:0046872|metal ion binding;GO:0043168|anion binding;GO:0036094|small molecule binding;GO:0097367|carbohydrate derivative binding;GO:0008144|drug binding;GO:0000166|nucleotide binding;GO:1901265|nucleoside phosphate binding;GO:0098772|molecular function regulator;GO:0005102|signaling receptor binding;GO:0005524|ATP binding;GO:0017076|purine nucleotide binding;GO:0030554|adenyl nucleotide binding;GO:0016740|transferase activity;GO:0032553|ribonucleotide binding;GO:0042802|identical protein binding;GO:0032555|purine ribonucleotide binding;GO:0032559|adenyl ribonucleotide binding;GO:0035639|purine ribonucleoside triphosphate binding;GO:0003676|nucleic acid binding;GO:0003690|double-stranded DNA binding;GO:0003677|DNA binding;GO:0140096|catalytic activity, acting on a protein;GO:1990837|sequence-specific double-stranded DNA binding;GO:0000976|transcription regulatory region sequence-specific DNA binding;GO:0019900|kinase binding;GO:0044212|transcription regulatory region DNA binding;GO:0001067|regulatory region nucleic acid binding;GO:0140110|transcription regulator activity;GO:0016772|transferase activity, transferring phosphorus-containing groups;GO:0043565|sequence-specific DNA binding;GO:0016301|kinase activity;GO:0016787|hydrolase activity;GO:0016773|phosphotransferase activity, alcohol group as acceptor;GO:0008289|lipid binding;GO:0030234|enzyme regulator activity;GO:0008134|transcription factor binding;GO:0019901|protein kinase binding;GO:0000987|proximal promoter sequence-specific DNA binding;GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding;GO:0001012|RNA polymerase II regulatory region DNA binding;GO:0005509|calcium ion binding;GO:0044877|protein-containing complex binding;GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding;GO:0004672|protein kinase activity;GO:0003700|DNA-binding transcription factor activity;GO:0008047|enzyme activator activity;GO:0019904|protein domain specific binding;GO:0008092|cytoskeletal protein binding;GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0030545|receptor regulator activity;GO:0050839|cell adhesion molecule binding;GO:0046983|protein dimerization activity;GO:0048018|receptor ligand activity;GO:0046914|transition metal ion binding;GO:0005201|extracellular matrix structural constituent;GO:0005198|structural molecule activity;GO:0004674|protein serine/threonine kinase activity;GO:0001664|G protein-coupled receptor binding;GO:0042803|protein homodimerization activity;GO:0005178|integrin binding;GO:0003712|transcription coregulator activity;GO:0005215|transporter activity;GO:0060589|nucleoside-triphosphatase regulator activity;GO:0016491|oxidoreductase activity;GO:0031072|heat shock protein binding;GO:0003779|actin binding;GO:0044389|ubiquitin-like protein ligase binding;GO:0060089|molecular transducer activity;GO:0008270|zinc ion binding;GO:0003682|chromatin binding;GO:0022857|transmembrane transporter activity;GO:0038023|signaling receptor activity;GO:0031625|ubiquitin protein ligase binding;GO:0047485|protein N-terminus binding;GO:0005543|phospholipid binding;GO:0016788|hydrolase activity, acting on ester bonds;GO:0030695|GTPase regulator activity;GO:0051020|GTPase binding;GO:0003723|RNA binding;GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific;GO:0098531|transcription factor activity, direct ligand regulated sequence-specific DNA binding;GO:0004879|nuclear receptor activity;GO:0005125|cytokine activity;GO:0002020|protease binding;GO:0008083|growth factor activity;GO:0005096|GTPase activator activity;GO:0005126|cytokine receptor binding;GO:0015075|ion transmembrane transporter activity;GO:0048037|cofactor binding	CTD_CHEMICALS_GOENRICH_MOLFUNCT|GO:0043167|ion binding;GO:1901363|heterocyclic compound binding;GO:0019899|enzyme binding;GO:0097159|organic cyclic compound binding;GO:0003824|catalytic activity;GO:0043169|cation binding;GO:0046872|metal ion binding;GO:0043168|anion binding;GO:0097367|carbohydrate derivative binding;GO:0008144|drug binding;GO:0042802|identical protein binding;GO:0036094|small molecule binding;GO:0032555|purine ribonucleotide binding;GO:0035639|purine ribonucleoside triphosphate binding;GO:0017076|purine nucleotide binding;GO:0032553|ribonucleotide binding;GO:0140096|catalytic activity, acting on a protein;GO:0044877|protein-containing complex binding;GO:0005102|signaling receptor binding;GO:0005524|ATP binding;GO:0032559|adenyl ribonucleotide binding;GO:0000166|nucleotide binding;GO:1901265|nucleoside phosphate binding;GO:0030554|adenyl nucleotide binding;GO:0140110|transcription regulator activity;GO:0003690|double-stranded DNA binding;GO:0003676|nucleic acid binding;GO:0005509|calcium ion binding;GO:0000976|transcription regulatory region sequence-specific DNA binding;GO:0044212|transcription regulatory region DNA binding;GO:0001067|regulatory region nucleic acid binding;GO:0043565|sequence-specific DNA binding;GO:1990837|sequence-specific double-stranded DNA binding;GO:0098772|molecular function regulator;GO:0016740|transferase activity;GO:0008092|cytoskeletal protein binding;GO:0016787|hydrolase activity;GO:0008134|transcription factor binding;GO:0005201|extracellular matrix structural constituent;GO:0008289|lipid binding;GO:0005198|structural molecule activity;GO:0019900|kinase binding;GO:0003677|DNA binding;GO:0050839|cell adhesion molecule binding;GO:0019904|protein domain specific binding;GO:0000977|RNA polymerase II regulatory region sequence-specific DNA binding;GO:0001012|RNA polymerase II regulatory region DNA binding;GO:0016301|kinase activity;GO:0016772|transferase activity, transferring phosphorus-containing groups;GO:0003712|transcription coregulator activity;GO:0030234|enzyme regulator activity;GO:0019901|protein kinase binding;GO:0005178|integrin binding;GO:0003779|actin binding;GO:0000987|proximal promoter sequence-specific DNA binding;GO:0003700|DNA-binding transcription factor activity;GO:0000978|RNA polymerase II proximal promoter sequence-specific DNA binding;GO:0046914|transition metal ion binding;GO:0016773|phosphotransferase activity, alcohol group as acceptor;GO:0000981|DNA-binding transcription factor activity, RNA polymerase II-specific;GO:0004672|protein kinase activity;GO:0003713|transcription coactivator activity;GO:0046983|protein dimerization activity;GO:0002020|protease binding;GO:0003723|RNA binding;GO:0005516|calmodulin binding;GO:0008270|zinc ion binding;GO:0003682|chromatin binding;GO:0001228|DNA-binding transcription activator activity, RNA polymerase II-specific;GO:0001664|G protein-coupled receptor binding;GO:0042803|protein homodimerization activity;GO:0005543|phospholipid binding	CTD_CHEMICALS_PATHWAYS|REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-5663202|Diseases of signal transduction;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-74752|Signaling by Insulin receptor;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-425407|SLC-mediated transmembrane transport;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-112316|Neuronal System;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-195721|Signaling by Wnt;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-5663205|Infectious disease;REACT:R-HSA-68886|M Phase;REACT:R-HSA-983169|Class I MHC mediated antigen processing & presentation;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-71387|Metabolism of carbohydrates;REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-167044|Signalling to RAS;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-73894|DNA Repair;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-983168|Antigen processing: Ubiquitination & Proteasome degradation;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-4839726|Chromatin organization;REACT:R-HSA-3247509|Chromatin modifying enzymes;KEGG:hsa04144|Endocytosis;KEGG:hsa04810|Regulation of actin cytoskeleton;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-373076|Class A/1 (Rhodopsin-like receptors);KEGG:hsa04014|Ras signaling pathway;KEGG:hsa04024|cAMP signaling pathway;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-397014|Muscle contraction;REACT:R-HSA-112315|Transmission across Chemical Synapses;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-1852241|Organelle biogenesis and maintenance;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-5357801|Programmed Cell Death;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-109581|Apoptosis;REACT:R-HSA-913531|Interferon Signaling;KEGG:hsa04360|Axon guidance;KEGG:hsa04080|Neuroactive ligand-receptor interaction;KEGG:hsa05203|Viral carcinogenesis	CTD_CHEMICALS_PATHWAYS|REACT:R-HSA-1430728|Metabolism;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa05204|Chemical carcinogenesis;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-168256|Immune System;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-392499|Metabolism of proteins	CTD_CHEMICALS_PATHWAYS|REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-109582|Hemostasis;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1266738|Developmental Biology;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-1640170|Cell Cycle;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1474244|Extracellular matrix organization;KEGG:hsa04110|Cell cycle;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-114608|Platelet degranulation;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-68877|Mitotic Prometaphase;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa01524|Platinum drug resistance;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-6791312|TP53 Regulates Transcription of Cell Cycle Genes;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-68886|M Phase;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-195258|RHO GTPase Effectors;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-211859|Biological oxidations;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2500257|Resolution of Sister Chromatid Cohesion;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa04015|Rap1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-140877|Formation of Fibrin Clot (Clotting Cascade);REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;KEGG:hsa04066|HIF-1 signaling pathway;REACT:R-HSA-425407|SLC-mediated transmembrane transport;KEGG:hsa04360|Axon guidance;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04210|Apoptosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-69206|G1/S Transition;REACT:R-HSA-453279|Mitotic G1-G1/S phases;KEGG:hsa05218|Melanoma;KEGG:hsa00982|Drug metabolism - cytochrome P450;KEGG:hsa05219|Bladder cancer;KEGG:hsa05215|Prostate cancer;REACT:R-HSA-109581|Apoptosis;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-5357801|Programmed Cell Death;KEGG:hsa04010|MAPK signaling pathway;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5663220|RHO GTPases Activate Formins;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04610|Complement and coagulation cascades;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa05222|Small cell lung cancer;REACT:R-HSA-5689880|Ub-specific processing proteases;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04014|Ras signaling pathway;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04976|Bile secretion;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-2424491|DAP12 signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04550|Signaling pathways regulating pluripotency of stem cells;REACT:R-HSA-5663202|Diseases of signal transduction;REACT:R-HSA-194138|Signaling by VEGF;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05224|Breast cancer;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-186763|Downstream signal transduction;KEGG:hsa04114|Oocyte meiosis;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-69620|Cell Cycle Checkpoints;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2555396|Mitotic Metaphase and Anaphase;KEGG:hsa04390|Hippo signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade	CTD_CHEMICALS_PATHWAYS|REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;REACT:R-HSA-1643685|Disease;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-2172127|DAP12 interactions;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-186797|Signaling by PDGF;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-191273|Cholesterol biosynthesis;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-166520|Signalling by NGF;KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-2428928|IRS-related events triggered by IGF1R;REACT:R-HSA-2428924|IGF1R signaling cascade;REACT:R-HSA-2404192|Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);REACT:R-HSA-451927|Interleukin-2 signaling;REACT:R-HSA-2871796|FCERI mediated MAPK activation;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;REACT:R-HSA-112399|IRS-mediated signalling;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-74751|Insulin receptor signalling cascade;REACT:R-HSA-912526|Interleukin receptor SHC signaling;REACT:R-HSA-74752|Signaling by Insulin receptor;KEGG:hsa05166|HTLV-I infection;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-179812|GRB2 events in EGFR signaling;REACT:R-HSA-180336|SHC1 events in EGFR signaling;REACT:R-HSA-5673001|RAF/MAP kinase cascade;REACT:R-HSA-112412|SOS-mediated signalling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-187706|Signalling to p38 via RIT and RIN;REACT:R-HSA-170968|Frs2-mediated activation;REACT:R-HSA-169893|Prolonged ERK activation events;REACT:R-HSA-167044|Signalling to RAS;KEGG:hsa05224|Breast cancer;KEGG:hsa05219|Bladder cancer;REACT:R-HSA-187687|Signalling to ERKs;KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa04066|HIF-1 signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-1655829|Regulation of cholesterol biosynthesis by SREBP (SREBF);REACT:R-HSA-1989781|PPARA activates gene expression;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2559583|Cellular Senescence;REACT:R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization;KEGG:hsa04210|Apoptosis;REACT:R-HSA-1257604|PIP3 activates AKT signaling;REACT:R-HSA-2426168|Activation of gene expression by SREBF (SREBP);KEGG:hsa05161|Hepatitis B;REACT:R-HSA-198203|PI3K/AKT activation;REACT:R-HSA-180292|GAB1 signalosome;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa05218|Melanoma;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa05169|Epstein-Barr virus infection;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa05230|Central carbon metabolism in cancer;KEGG:hsa01522|Endocrine resistance;REACT:R-HSA-112409|RAF-independent MAPK1/3 activation;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-5688426|Deubiquitination;REACT:R-HSA-382551|Transmembrane transport of small molecules;KEGG:hsa04014|Ras signaling pathway;REACT:R-HSA-69278|Cell Cycle, Mitotic	CTD_CHEMICALS_PATHWAYS|REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;KEGG:hsa05204|Chemical carcinogenesis;KEGG:hsa01100|Metabolic pathways;KEGG:hsa00140|Steroid hormone biosynthesis;KEGG:hsa00982|Drug metabolism - cytochrome P450;REACT:R-HSA-211897|Cytochrome P450 - arranged by substrate type;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-156580|Phase II conjugation;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-168256|Immune System;REACT:R-HSA-196854|Metabolism of vitamins and cofactors;REACT:R-HSA-5663205|Infectious disease;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-1643685|Disease;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-71291|Metabolism of amino acids and derivatives;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-2262752|Cellular responses to stress	CTD_CHEMICALS_PATHWAYS|REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa01100|Metabolic pathways;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-382551|Transmembrane transport of small molecules	CTD_CHEMICALS_PATHWAYS|REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;REACT:R-HSA-168249|Innate Immune System;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;KEGG:hsa05200|Pathways in cancer;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;KEGG:hsa04060|Cytokine-cytokine receptor interaction;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-372790|Signaling by GPCR;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04510|Focal adhesion;REACT:R-HSA-597592|Post-translational protein modification;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;KEGG:hsa04115|p53 signaling pathway;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04151|PI3K-Akt signaling pathway;REACT:R-HSA-881907|Gastrin-CREB signalling pathway via PKC and MAPK;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-1643685|Disease;KEGG:hsa05164|Influenza A;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-212436|Generic Transcription Pathway;REACT:R-HSA-2424491|DAP12 signaling;REACT:R-HSA-388396|GPCR downstream signaling;REACT:R-HSA-2172127|DAP12 interactions;KEGG:hsa05205|Proteoglycans in cancer;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-1433557|Signaling by SCF-KIT;REACT:R-HSA-1368108|BMAL1:CLOCK,NPAS2 activates circadian gene expression;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-5683057|MAPK family signaling cascades;REACT:R-HSA-194138|Signaling by VEGF;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-177929|Signaling by EGFR;KEGG:hsa04668|TNF signaling pathway;KEGG:hsa05161|Hepatitis B;REACT:R-HSA-4420097|VEGFA-VEGFR2 Pathway;REACT:R-HSA-512988|Interleukin-3, 5 and GM-CSF signaling;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-983705|Signaling by the B Cell Receptor (BCR);REACT:R-HSA-2262752|Cellular responses to stress;KEGG:hsa04640|Hematopoietic cell lineage;REACT:R-HSA-199991|Membrane Trafficking;KEGG:hsa05160|Hepatitis C;KEGG:hsa04662|B cell receptor signaling pathway;KEGG:hsa04068|FoxO signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa05162|Measles;REACT:R-HSA-400253|Circadian Clock;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1168372|Downstream signaling events of B Cell Receptor (BCR);KEGG:hsa05202|Transcriptional misregulation in cancer;KEGG:hsa05169|Epstein-Barr virus infection;KEGG:hsa05418|Fluid shear stress and atherosclerosis;KEGG:hsa05224|Breast cancer;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;REACT:R-HSA-2871796|FCERI mediated MAPK activation;KEGG:hsa04710|Circadian rhythm;KEGG:hsa05219|Bladder cancer;KEGG:hsa04064|NF-kappa B signaling pathway;KEGG:hsa01522|Endocrine resistance;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-500792|GPCR ligand binding;REACT:R-HSA-375165|NCAM signaling for neurite out-growth;REACT:R-HSA-72163|mRNA Splicing - Major Pathway;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-5218921|VEGFR2 mediated cell proliferation;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-187687|Signalling to ERKs;REACT:R-HSA-72172|mRNA Splicing;KEGG:hsa04012|ErbB signaling pathway;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05140|Leishmaniasis;REACT:R-HSA-8853659|RET signaling;REACT:R-HSA-170984|ARMS-mediated activation;REACT:R-HSA-380108|Chemokine receptors bind chemokines;REACT:R-HSA-5684996|MAPK1/MAPK3 signaling;REACT:R-HSA-6798695|Neutrophil degranulation;REACT:R-HSA-169893|Prolonged ERK activation events;KEGG:hsa05133|Pertussis;REACT:R-HSA-2586552|Signaling by Leptin;REACT:R-HSA-912526|Interleukin receptor SHC signaling;KEGG:hsa04657|IL-17 signaling pathway;REACT:R-HSA-375276|Peptide ligand-binding receptors	CTD_CHEMICALS_PATHWAYS|REACT:R-HSA-162582|Signal Transduction;REACT:R-HSA-168256|Immune System;REACT:R-HSA-1430728|Metabolism;REACT:R-HSA-1474244|Extracellular matrix organization;REACT:R-HSA-74160|Gene Expression;REACT:R-HSA-392499|Metabolism of proteins;REACT:R-HSA-1266738|Developmental Biology;REACT:R-HSA-168249|Innate Immune System;KEGG:hsa04933|AGE-RAGE signaling pathway in diabetic complications;REACT:R-HSA-6785807|Interleukin-4 and 13 signaling;REACT:R-HSA-109582|Hemostasis;REACT:R-HSA-449147|Signaling by Interleukins;REACT:R-HSA-1280215|Cytokine Signaling in Immune system;KEGG:hsa05200|Pathways in cancer;REACT:R-HSA-597592|Post-translational protein modification;KEGG:hsa04510|Focal adhesion;KEGG:hsa01100|Metabolic pathways;KEGG:hsa04115|p53 signaling pathway;KEGG:hsa04151|PI3K-Akt signaling pathway;KEGG:hsa04512|ECM-receptor interaction;REACT:R-HSA-556833|Metabolism of lipids and lipoproteins;REACT:R-HSA-212436|Generic Transcription Pathway;KEGG:hsa04668|TNF signaling pathway;REACT:R-HSA-422475|Axon guidance;REACT:R-HSA-216083|Integrin cell surface interactions;REACT:R-HSA-6798695|Neutrophil degranulation;KEGG:hsa05206|MicroRNAs in cancer;REACT:R-HSA-3700989|Transcriptional Regulation by TP53;REACT:R-HSA-397014|Muscle contraction;KEGG:hsa05146|Amoebiasis;REACT:R-HSA-76002|Platelet activation, signaling and aggregation;REACT:R-HSA-3000178|ECM proteoglycans;REACT:R-HSA-195258|RHO GTPase Effectors;REACT:R-HSA-194315|Signaling by Rho GTPases;REACT:R-HSA-1640170|Cell Cycle;KEGG:hsa05418|Fluid shear stress and atherosclerosis;REACT:R-HSA-166520|Signalling by NGF;REACT:R-HSA-1989781|PPARA activates gene expression;KEGG:hsa04010|MAPK signaling pathway;REACT:R-HSA-400206|Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);KEGG:hsa04921|Oxytocin signaling pathway;KEGG:hsa04390|Hippo signaling pathway;KEGG:hsa04062|Chemokine signaling pathway;KEGG:hsa04371|Apelin signaling pathway;REACT:R-HSA-1280218|Adaptive Immune System;REACT:R-HSA-372790|Signaling by GPCR;KEGG:hsa05161|Hepatitis B;KEGG:hsa04932|Non-alcoholic fatty liver disease (NAFLD);KEGG:hsa05205|Proteoglycans in cancer;KEGG:hsa05202|Transcriptional misregulation in cancer;REACT:R-HSA-186797|Signaling by PDGF;KEGG:hsa05168|Herpes simplex infection;REACT:R-HSA-2454202|Fc epsilon receptor (FCERI) signaling;KEGG:hsa04974|Protein digestion and absorption;REACT:R-HSA-446203|Asparagine N-linked glycosylation;REACT:R-HSA-535734|Fatty acid, triacylglycerol, and ketone body metabolism;REACT:R-HSA-211859|Biological oxidations;KEGG:hsa00980|Metabolism of xenobiotics by cytochrome P450;REACT:R-HSA-382551|Transmembrane transport of small molecules;REACT:R-HSA-1643685|Disease;KEGG:hsa04360|Axon guidance;KEGG:hsa04611|Platelet activation;REACT:R-HSA-2262752|Cellular responses to stress;REACT:R-HSA-5653656|Vesicle-mediated transport;REACT:R-HSA-187037|NGF signalling via TRKA from the plasma membrane;REACT:R-HSA-1500931|Cell-Cell communication;REACT:R-HSA-69278|Cell Cycle, Mitotic;REACT:R-HSA-388396|GPCR downstream signaling;KEGG:hsa05166|HTLV-I infection;REACT:R-HSA-381340|Transcriptional regulation of white adipocyte differentiation;KEGG:hsa04210|Apoptosis;KEGG:hsa05323|Rheumatoid arthritis;KEGG:hsa04141|Protein processing in endoplasmic reticulum;KEGG:hsa04530|Tight junction;REACT:R-HSA-202733|Cell surface interactions at the vascular wall;REACT:R-HSA-195721|Signaling by Wnt;KEGG:hsa05203|Viral carcinogenesis;KEGG:hsa03013|RNA transport;REACT:R-HSA-1474290|Collagen formation;REACT:R-HSA-5625740|RHO GTPases activate PKNs;KEGG:hsa04060|Cytokine-cytokine receptor interaction;KEGG:hsa01522|Endocrine resistance;KEGG:hsa04640|Hematopoietic cell lineage;KEGG:hsa04015|Rap1 signaling pathway;REACT:R-HSA-72203|Processing of Capped Intron-Containing Pre-mRNA;KEGG:hsa05142|Chagas disease (American trypanosomiasis);KEGG:hsa04620|Toll-like receptor signaling pathway;REACT:R-HSA-114608|Platelet degranulation;KEGG:hsa04022|cGMP-PKG signaling pathway;REACT:R-HSA-211945|Phase 1 - Functionalization of compounds;REACT:R-HSA-76005|Response to elevated platelet cytosolic Ca2+;REACT:R-HSA-1474228|Degradation of the extracellular matrix;KEGG:hsa05145|Toxoplasmosis;REACT:R-HSA-201681|TCF dependent signaling in response to WNT;KEGG:hsa05164|Influenza A;KEGG:hsa05224|Breast cancer;KEGG:hsa04919|Thyroid hormone signaling pathway;REACT:R-HSA-186763|Downstream signal transduction;REACT:R-HSA-177929|Signaling by EGFR;REACT:R-HSA-1433557|Signaling by SCF-KIT	CTD_PATHWAY|KEGG:00010|Glycolysis / Gluconeogenesis	CTD_PATHWAY|KEGG:00020|Citrate cycle (TCA cycle)	CTD_PATHWAY|KEGG:00030|Pentose phosphate pathway	CTD_PATHWAY|KEGG:00040|Pentose and glucuronate interconversions	CTD_PATHWAY|KEGG:00051|Fructose and mannose metabolism	CTD_PATHWAY|KEGG:00052|Galactose metabolism	CTD_PATHWAY|KEGG:00053|Ascorbate and aldarate metabolism	CTD_PATHWAY|KEGG:00071|Fatty acid metabolism	CTD_PATHWAY|KEGG:00072|Synthesis and degradation of ketone bodies	CTD_PATHWAY|KEGG:00100|Steroid biosynthesis	CTD_PATHWAY|KEGG:00120|Primary bile acid biosynthesis	CTD_PATHWAY|KEGG:00140|Steroid hormone biosynthesis	CTD_PATHWAY|KEGG:00190|Oxidative phosphorylation	CTD_PATHWAY|KEGG:00230|Purine metabolism	CTD_PATHWAY|KEGG:00240|Pyrimidine metabolism	CTD_PATHWAY|KEGG:00250|Alanine, aspartate and glutamate metabolism	CTD_PATHWAY|KEGG:00260|Glycine, serine and threonine metabolism	CTD_PATHWAY|KEGG:00270|Cysteine and methionine metabolism	CTD_PATHWAY|KEGG:00280|Valine, leucine and isoleucine degradation	CTD_PATHWAY|KEGG:00290|Valine, leucine and isoleucine biosynthesis	CTD_PATHWAY|KEGG:00310|Lysine degradation	CTD_PATHWAY|KEGG:00330|Arginine and proline metabolism	CTD_PATHWAY|KEGG:00340|Histidine metabolism	CTD_PATHWAY|KEGG:00350|Tyrosine metabolism	CTD_PATHWAY|KEGG:00360|Phenylalanine metabolism	CTD_PATHWAY|KEGG:00380|Tryptophan metabolism	CTD_PATHWAY|KEGG:00410|beta-Alanine metabolism	CTD_PATHWAY|KEGG:00430|Taurine and hypotaurine metabolism	CTD_PATHWAY|KEGG:00450|Selenocompound metabolism	CTD_PATHWAY|KEGG:00480|Glutathione metabolism	CTD_PATHWAY|KEGG:00500|Starch and sucrose metabolism	CTD_PATHWAY|KEGG:00510|N-Glycan biosynthesis	CTD_PATHWAY|KEGG:00511|Other glycan degradation	CTD_PATHWAY|KEGG:00512|Mucin type O-Glycan biosynthesis	CTD_PATHWAY|KEGG:00514|Other types of O-glycan biosynthesis	CTD_PATHWAY|KEGG:00520|Amino sugar and nucleotide sugar metabolism	CTD_PATHWAY|KEGG:00532|Glycosaminoglycan biosynthesis - chondroitin sulfate	CTD_PATHWAY|KEGG:00534|Glycosaminoglycan biosynthesis - heparan sulfate	CTD_PATHWAY|KEGG:00561|Glycerolipid metabolism	CTD_PATHWAY|KEGG:00562|Inositol phosphate metabolism	CTD_PATHWAY|KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	CTD_PATHWAY|KEGG:00564|Glycerophospholipid metabolism	CTD_PATHWAY|KEGG:00565|Ether lipid metabolism	CTD_PATHWAY|KEGG:00590|Arachidonic acid metabolism	CTD_PATHWAY|KEGG:00591|Linoleic acid metabolism	CTD_PATHWAY|KEGG:00600|Sphingolipid metabolism	CTD_PATHWAY|KEGG:00601|Glycosphingolipid biosynthesis - lacto and neolacto series	CTD_PATHWAY|KEGG:00603|Glycosphingolipid biosynthesis - globo series	CTD_PATHWAY|KEGG:00604|Glycosphingolipid biosynthesis - ganglio series	CTD_PATHWAY|KEGG:00620|Pyruvate metabolism	CTD_PATHWAY|KEGG:00630|Glyoxylate and dicarboxylate metabolism	CTD_PATHWAY|KEGG:00640|Propanoate metabolism	CTD_PATHWAY|KEGG:00650|Butanoate metabolism	CTD_PATHWAY|KEGG:00670|One carbon pool by folate	CTD_PATHWAY|KEGG:00760|Nicotinate and nicotinamide metabolism	CTD_PATHWAY|KEGG:00830|Retinol metabolism	CTD_PATHWAY|KEGG:00860|Porphyrin and chlorophyll metabolism	CTD_PATHWAY|KEGG:00900|Terpenoid backbone biosynthesis	CTD_PATHWAY|KEGG:00910|Nitrogen metabolism	CTD_PATHWAY|KEGG:00920|Sulfur metabolism	CTD_PATHWAY|KEGG:00970|Aminoacyl-tRNA biosynthesis	CTD_PATHWAY|KEGG:00980|Metabolism of xenobiotics by cytochrome P450	CTD_PATHWAY|KEGG:00982|Drug metabolism - cytochrome P450	CTD_PATHWAY|KEGG:00983|Drug metabolism - other enzymes	CTD_PATHWAY|KEGG:01040|Biosynthesis of unsaturated fatty acids	CTD_PATHWAY|KEGG:01100|Metabolic pathways	CTD_PATHWAY|KEGG:02010|ABC transporters	CTD_PATHWAY|KEGG:03008|Ribosome biogenesis in eukaryotes	CTD_PATHWAY|KEGG:03010|Ribosome	CTD_PATHWAY|KEGG:03013|RNA transport	CTD_PATHWAY|KEGG:03015|mRNA surveillance pathway	CTD_PATHWAY|KEGG:03018|RNA degradation	CTD_PATHWAY|KEGG:03020|RNA polymerase	CTD_PATHWAY|KEGG:03022|Basal transcription factors	CTD_PATHWAY|KEGG:03030|DNA replication	CTD_PATHWAY|KEGG:03040|Spliceosome	CTD_PATHWAY|KEGG:03050|Proteasome	CTD_PATHWAY|KEGG:03060|Protein export	CTD_PATHWAY|KEGG:03320|PPAR signaling pathway	CTD_PATHWAY|KEGG:03410|Base excision repair	CTD_PATHWAY|KEGG:03420|Nucleotide excision repair	CTD_PATHWAY|KEGG:03430|Mismatch repair	CTD_PATHWAY|KEGG:03440|Homologous recombination	CTD_PATHWAY|KEGG:03450|Non-homologous end-joining	CTD_PATHWAY|KEGG:04010|MAPK signaling pathway	CTD_PATHWAY|KEGG:04012|ErbB signaling pathway	CTD_PATHWAY|KEGG:04020|Calcium signaling pathway	CTD_PATHWAY|KEGG:04060|Cytokine-cytokine receptor interaction	CTD_PATHWAY|KEGG:04062|Chemokine signaling pathway	CTD_PATHWAY|KEGG:04070|Phosphatidylinositol signaling system	CTD_PATHWAY|KEGG:04080|Neuroactive ligand-receptor interaction	CTD_PATHWAY|KEGG:04110|Cell cycle	CTD_PATHWAY|KEGG:04114|Oocyte meiosis	CTD_PATHWAY|KEGG:04115|p53 signaling pathway	CTD_PATHWAY|KEGG:04120|Ubiquitin mediated proteolysis	CTD_PATHWAY|KEGG:04130|SNARE interactions in vesicular transport	CTD_PATHWAY|KEGG:04141|Protein processing in endoplasmic reticulum	CTD_PATHWAY|KEGG:04142|Lysosome	CTD_PATHWAY|KEGG:04144|Endocytosis	CTD_PATHWAY|KEGG:04145|Phagosome	CTD_PATHWAY|KEGG:04146|Peroxisome	CTD_PATHWAY|KEGG:04150|mTOR signaling pathway	CTD_PATHWAY|KEGG:04210|Apoptosis	CTD_PATHWAY|KEGG:04260|Cardiac muscle contraction	CTD_PATHWAY|KEGG:04270|Vascular smooth muscle contraction	CTD_PATHWAY|KEGG:04310|Wnt signaling pathway	CTD_PATHWAY|KEGG:04320|Dorso-ventral axis formation	CTD_PATHWAY|KEGG:04330|Notch signaling pathway	CTD_PATHWAY|KEGG:04340|Hedgehog signaling pathway	CTD_PATHWAY|KEGG:04350|TGF-beta signaling pathway	CTD_PATHWAY|KEGG:04360|Axon guidance	CTD_PATHWAY|KEGG:04370|VEGF signaling pathway	CTD_PATHWAY|KEGG:04380|Osteoclast differentiation	CTD_PATHWAY|KEGG:04510|Focal adhesion	CTD_PATHWAY|KEGG:04512|ECM-receptor interaction	CTD_PATHWAY|KEGG:04514|Cell adhesion molecules (CAMs)	CTD_PATHWAY|KEGG:04520|Adherens junction	CTD_PATHWAY|KEGG:04530|Tight junction	CTD_PATHWAY|KEGG:04540|Gap junction	CTD_PATHWAY|KEGG:04610|Complement and coagulation cascades	CTD_PATHWAY|KEGG:04612|Antigen processing and presentation	CTD_PATHWAY|KEGG:04614|Renin-angiotensin system	CTD_PATHWAY|KEGG:04620|Toll-like receptor signaling pathway	CTD_PATHWAY|KEGG:04621|NOD-like receptor signaling pathway	CTD_PATHWAY|KEGG:04622|RIG-I-like receptor signaling pathway	CTD_PATHWAY|KEGG:04623|Cytosolic DNA-sensing pathway	CTD_PATHWAY|KEGG:04630|Jak-STAT signaling pathway	CTD_PATHWAY|KEGG:04640|Hematopoietic cell lineage	CTD_PATHWAY|KEGG:04650|Natural killer cell mediated cytotoxicity	CTD_PATHWAY|KEGG:04660|T cell receptor signaling pathway	CTD_PATHWAY|KEGG:04662|B cell receptor signaling pathway	CTD_PATHWAY|KEGG:04664|Fc epsilon RI signaling pathway	CTD_PATHWAY|KEGG:04666|Fc gamma R-mediated phagocytosis	CTD_PATHWAY|KEGG:04670|Leukocyte transendothelial migration	CTD_PATHWAY|KEGG:04672|Intestinal immune network for IgA production	CTD_PATHWAY|KEGG:04710|Circadian rhythm - mammal	CTD_PATHWAY|KEGG:04720|Long-term potentiation	CTD_PATHWAY|KEGG:04722|Neurotrophin signaling pathway	CTD_PATHWAY|KEGG:04724|Glutamatergic synapse	CTD_PATHWAY|KEGG:04730|Long-term depression	CTD_PATHWAY|KEGG:04810|Regulation of actin cytoskeleton	CTD_PATHWAY|KEGG:04910|Insulin signaling pathway	CTD_PATHWAY|KEGG:04912|GnRH signaling pathway	CTD_PATHWAY|KEGG:04914|Progesterone-mediated oocyte maturation	CTD_PATHWAY|KEGG:04916|Melanogenesis	CTD_PATHWAY|KEGG:04920|Adipocytokine signaling pathway	CTD_PATHWAY|KEGG:04930|Type II diabetes mellitus	CTD_PATHWAY|KEGG:04940|Type I diabetes mellitus	CTD_PATHWAY|KEGG:04950|Maturity onset diabetes of the young	CTD_PATHWAY|KEGG:04960|Aldosterone-regulated sodium reabsorption	CTD_PATHWAY|KEGG:04961|Endocrine and other factor-regulated calcium reabsorption	CTD_PATHWAY|KEGG:04962|Vasopressin-regulated water reabsorption	CTD_PATHWAY|KEGG:04964|Proximal tubule bicarbonate reclamation	CTD_PATHWAY|KEGG:04966|Collecting duct acid secretion	CTD_PATHWAY|KEGG:04970|Salivary secretion	CTD_PATHWAY|KEGG:04971|Gastric acid secretion	CTD_PATHWAY|KEGG:04972|Pancreatic secretion	CTD_PATHWAY|KEGG:04973|Carbohydrate digestion and absorption	CTD_PATHWAY|KEGG:04974|Protein digestion and absorption	CTD_PATHWAY|KEGG:04975|Fat digestion and absorption	CTD_PATHWAY|KEGG:04976|Bile secretion	CTD_PATHWAY|KEGG:04978|Mineral absorption	CTD_PATHWAY|KEGG:05010|Alzheimer's disease	CTD_PATHWAY|KEGG:05012|Parkinson's disease	CTD_PATHWAY|KEGG:05014|Amyotrophic lateral sclerosis (ALS)	CTD_PATHWAY|KEGG:05016|Huntington's disease	CTD_PATHWAY|KEGG:05020|Prion diseases	CTD_PATHWAY|KEGG:05100|Bacterial invasion of epithelial cells	CTD_PATHWAY|KEGG:05110|Vibrio cholerae infection	CTD_PATHWAY|KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection	CTD_PATHWAY|KEGG:05130|Pathogenic Escherichia coli infection	CTD_PATHWAY|KEGG:05131|Shigellosis	CTD_PATHWAY|KEGG:05140|Leishmaniasis	CTD_PATHWAY|KEGG:05142|Chagas disease (American trypanosomiasis)	CTD_PATHWAY|KEGG:05143|African trypanosomiasis	CTD_PATHWAY|KEGG:05144|Malaria	CTD_PATHWAY|KEGG:05145|Toxoplasmosis	CTD_PATHWAY|KEGG:05146|Amoebiasis	CTD_PATHWAY|KEGG:05150|Staphylococcus aureus infection	CTD_PATHWAY|KEGG:05152|Tuberculosis	CTD_PATHWAY|KEGG:05160|Hepatitis C	CTD_PATHWAY|KEGG:05162|Measles	CTD_PATHWAY|KEGG:05200|Pathways in cancer	CTD_PATHWAY|KEGG:05210|Colorectal cancer	CTD_PATHWAY|KEGG:05211|Renal cell carcinoma	CTD_PATHWAY|KEGG:05212|Pancreatic cancer	CTD_PATHWAY|KEGG:05213|Endometrial cancer	CTD_PATHWAY|KEGG:05214|Glioma	CTD_PATHWAY|KEGG:05215|Prostate cancer	CTD_PATHWAY|KEGG:05216|Thyroid cancer	CTD_PATHWAY|KEGG:05217|Basal cell carcinoma	CTD_PATHWAY|KEGG:05218|Melanoma	CTD_PATHWAY|KEGG:05219|Bladder cancer	CTD_PATHWAY|KEGG:05220|Chronic myeloid leukemia	CTD_PATHWAY|KEGG:05221|Acute myeloid leukemia	CTD_PATHWAY|KEGG:05222|Small cell lung cancer	CTD_PATHWAY|KEGG:05223|Non-small cell lung cancer	CTD_PATHWAY|KEGG:05310|Asthma	CTD_PATHWAY|KEGG:05320|Autoimmune thyroid disease	CTD_PATHWAY|KEGG:05322|Systemic lupus erythematosus	CTD_PATHWAY|KEGG:05323|Rheumatoid arthritis	CTD_PATHWAY|KEGG:05330|Allograft rejection	CTD_PATHWAY|KEGG:05332|Graft-versus-host disease	CTD_PATHWAY|KEGG:05340|Primary immunodeficiency	CTD_PATHWAY|KEGG:05410|Hypertrophic cardiomyopathy (HCM)	CTD_PATHWAY|KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)	CTD_PATHWAY|KEGG:05414|Dilated cardiomyopathy	CTD_PATHWAY|KEGG:05416|Viral myocarditis	HTS_ACTIVE|activation_ATAD5	HTS_ACTIVE|activation_EndoRS	HTS_ACTIVE|activation_H2AX	HTS_ACTIVE|activation_Nrf2	HTS_ACTIVE|activation_p53	HTS_ACTIVE|agonism_AR/full	HTS_ACTIVE|agonism_AR/partial	HTS_ACTIVE|agonism_AhR	HTS_ACTIVE|agonism_ER/full	HTS_ACTIVE|agonism_ER/partial	HTS_ACTIVE|agonism_FXR	HTS_ACTIVE|agonism_GR	HTS_ACTIVE|agonism_PPARd	HTS_ACTIVE|agonism_PPARg	HTS_ACTIVE|agonism_RSP	HTS_ACTIVE|agonism_VDR	HTS_ACTIVE|antagonism_AR/full/run1	HTS_ACTIVE|antagonism_AR/full/run2	HTS_ACTIVE|antagonism_ER/full	HTS_ACTIVE|cytotoxicity_AR/antagonism/partial	HTS_ACTIVE|cytotoxicity_MMP/inhibition	HTS_ACTIVE|cytotoxicity_RSP/agonism	HTS_ACTIVE|cytotoxicity_RXR/agonism	HTS_ACTIVE|inhibition_MMP	KNOWN_TOXICITY|Blood & Bone Marrow Toxicity	KNOWN_TOXICITY|Carcinogenicity	KNOWN_TOXICITY|Embryo/Fetal Toxicity	KNOWN_TOXICITY|Mutagenicity	LEADSCOPE_TOXICITY|Genetic Toxicity -E. coli	LEADSCOPE_TOXICITY|Genetic Toxicity -In vitro chrom. ab. CHL	LEADSCOPE_TOXICITY|Genetic Toxicity -In vitro composite	LEADSCOPE_TOXICITY|Genetic Toxicity -SCE in vitro	LEADSCOPE_TOXICITY|Genetic Toxicity -SCE in vitro CHO	LEADSCOPE_TOXICITY|Genetic Toxicity -SCE in vitro other cells	LEADSCOPE_TOXICITY|Genetic Toxicity -UDS	LEADSCOPE_TOXICITY|Genetic Toxicity -UDS human lymphocytes	LEADSCOPE_TOXICITY|Genetic Toxicity -UDS rat hepatocytes	LEADSCOPE_TOXICITY|Genetic Toxicity -drosophila HT	LEADSCOPE_TOXICITY|Genetic Toxicity -drosophila SLRL	LEADSCOPE_TOXICITY|Genetic Toxicity -microbial	LEADSCOPE_TOXICITY|Genetic Toxicity -mouse lymphoma	LEADSCOPE_TOXICITY|Genetic Toxicity -salmonella	LEADSCOPE_TOXICITY|Human Adverse Cardiological Effects -bradycardia	LEADSCOPE_TOXICITY|Reproductive Toxicity- C3H10T1-2	LEADSCOPE_TOXICITY|Reproductive Toxicity- sperm mouse	LEADSCOPE_TOXICITY|Reproductive Toxicity-SHE	LEADSCOPE_TOXICITY|Reproductive Toxicity-cell transformation	MECHANISM|Inhibit DNA synthesis, repair, and function	MESH|Acenaphthenes	MESH|Anthracenes	MESH|Benz(a)Anthracenes	MESH|Benzo(a)pyrene	MESH|Benzopyrenes	MESH|Chrysenes	MESH|Fluorenes	MESH|Hydrocarbons	MESH|Hydrocarbons, Aromatic	MESH|Hydrocarbons, Cyclic	MESH|Naphthalenes	MESH|Organic Chemicals	MESH|Perylene	MESH|Phenalenes	MESH|Phenanthrenes	MESH|Polycyclic Compounds	MESH|Polycyclic Hydrocarbons, Aromatic	MESH|Pyrenes	MODE_CLASS|Distorts /blocks macromolecular scaffold function	MULTICASE_TOX_PREDICTION|ARE activation in keratinocytes at 100uM	MULTICASE_TOX_PREDICTION|ARE activation in keratinocytes at 1mM	MULTICASE_TOX_PREDICTION|BCRP inhibition at 10uM	MULTICASE_TOX_PREDICTION|BSEP inhibition at 100uM	MULTICASE_TOX_PREDICTION|BSEP inhibition at 10uM	MULTICASE_TOX_PREDICTION|Dendritic cell activation at 1mM (CD86, CD54)	MULTICASE_TOX_PREDICTION|Draize skin test, 24h, rabbit	MULTICASE_TOX_PREDICTION|Extent of human metabolism, %	MULTICASE_TOX_PREDICTION|Haptenation (DPRA, SH test)	MULTICASE_TOX_PREDICTION|Human plasma protein binding, %bound	MULTICASE_TOX_PREDICTION|Human volume of distribution (L/kg)	MULTICASE_TOX_PREDICTION|Local lymph node assay, mouse, extreme sensitizers (EC3 < 1%)	MULTICASE_TOX_PREDICTION|Local lymph node assay, mouse, moderate sensitizers (EC3 < 10%)	MULTICASE_TOX_PREDICTION|Local lymph node assay, mouse, weak sensitizers (EC3 < 100%)	MULTICASE_TOX_PREDICTION|MCT1 inhibition at 10uM	MULTICASE_TOX_PREDICTION|MRP1 inhibition at 10uM	MULTICASE_TOX_PREDICTION|MRP5 inhibition at 50uM	MULTICASE_TOX_PREDICTION|OCT1 inhibition at 100uM	MULTICASE_TOX_PREDICTION|RCA fetal death, mouse	MULTICASE_TOX_PREDICTION|RCA fetal death, rat	MULTICASE_TOX_PREDICTION|RCA fetal death, rodent	MULTICASE_TOX_PREDICTION|RCA fetal weight decrease, mouse	MULTICASE_TOX_PREDICTION|RCA survival post-implantation, mouse	MULTICASE_TOX_PREDICTION|RCA survival post-implantation, rodent	MULTICASE_TOX_PREDICTION|RCA survival pre-implantation, mouse	MULTICASE_TOX_PREDICTION|Sensory irritation, mouse	MULTICASE_TOX_PREDICTION|Tox21 ARE activation assay, only strong actives by NIEHS calls, research only	MULTICASE_TOX_PREDICTION|Tox21 ARE activation assay, strong and weak actives by NIEHS calls, research only	PHARMACTIONLIST|Carcinogens	PHARMACTIONLIST|Chemical Actions and Uses	PHARMACTIONLIST|Coloring Agents	PHARMACTIONLIST|Enzyme Inhibitors	PHARMACTIONLIST|Fluorescent Dyes	PHARMACTIONLIST|Indicators and Reagents	PHARMACTIONLIST|Laboratory Chemicals	PHARMACTIONLIST|Luminescent Agents	PHARMACTIONLIST|Molecular Mechanisms of Pharmacological Action	PHARMACTIONLIST|Noxae	PHARMACTIONLIST|Pharmacologic Actions	PHARMACTIONLIST|Specialty Uses of Chemicals	PHARMACTIONLIST|Toxic Actions	PRODUCT_CLASS|Toxicants	STRUCTURE_ACTIVITY|Toxicant, Ah receptor agonist	TISSUE_TOXICITY|Anemia	TISSUE_TOXICITY|Carcinogenicity	TISSUE_TOXICITY|Genotoxicity	TISSUE_TOXICITY|Red Blood Cell Damage	TISSUE_TOXICITY|Teratogenicity	TOXCAST_ACTIVE|APR_HepG2_CellCycleArrest_24h_dn	TOXCAST_ACTIVE|APR_HepG2_CellCycleArrest_72h_dn	TOXCAST_ACTIVE|APR_HepG2_CellLoss_24h_dn	TOXCAST_ACTIVE|APR_HepG2_CellLoss_72h_dn	TOXCAST_ACTIVE|APR_HepG2_MitoMass_24h_up	TOXCAST_ACTIVE|APR_HepG2_MitoMembPot_24h_dn	TOXCAST_ACTIVE|APR_HepG2_MitoMembPot_72h_dn	TOXCAST_ACTIVE|APR_HepG2_MitoticArrest_24h_up	TOXCAST_ACTIVE|APR_HepG2_MitoticArrest_72h_up	TOXCAST_ACTIVE|APR_HepG2_NuclearSize_24h_dn	TOXCAST_ACTIVE|APR_HepG2_NuclearSize_72h_dn	TOXCAST_ACTIVE|APR_HepG2_OxidativeStress_24h_up	TOXCAST_ACTIVE|APR_HepG2_OxidativeStress_72h_up	TOXCAST_ACTIVE|APR_HepG2_p53Act_24h_dn	TOXCAST_ACTIVE|ATG_Ahr_CIS_up	TOXCAST_ACTIVE|ATG_CMV_CIS_up	TOXCAST_ACTIVE|ATG_DR5_CIS_up	TOXCAST_ACTIVE|ATG_ERE_CIS_up	TOXCAST_ACTIVE|ATG_ERa_TRANS_up	TOXCAST_ACTIVE|ATG_FoxA2_CIS_up	TOXCAST_ACTIVE|ATG_HIF1a_CIS_up	TOXCAST_ACTIVE|ATG_Myc_CIS_up	TOXCAST_ACTIVE|ATG_NRF2_ARE_CIS_up	TOXCAST_ACTIVE|ATG_NURR1_TRANS_up	TOXCAST_ACTIVE|ATG_PPARg_TRANS_up	TOXCAST_ACTIVE|ATG_PXRE_CIS_up	TOXCAST_ACTIVE|ATG_PXR_TRANS_up	TOXCAST_ACTIVE|ATG_RXRb_TRANS_up	TOXCAST_ACTIVE|BSK_3C_HLADR_down	TOXCAST_ACTIVE|BSK_3C_MCP1_down	TOXCAST_ACTIVE|BSK_3C_Proliferation_down	TOXCAST_ACTIVE|BSK_3C_SRB_down	TOXCAST_ACTIVE|BSK_3C_TissueFactor_down	TOXCAST_ACTIVE|BSK_3C_Vis_down	TOXCAST_ACTIVE|BSK_4H_Eotaxin3_down	TOXCAST_ACTIVE|BSK_4H_MCP1_down	TOXCAST_ACTIVE|BSK_4H_VCAM1_down	TOXCAST_ACTIVE|BSK_4H_VEGFRII_down	TOXCAST_ACTIVE|BSK_4H_uPAR_down	TOXCAST_ACTIVE|BSK_BE3C_HLADR_down	TOXCAST_ACTIVE|BSK_BE3C_MMP1_down	TOXCAST_ACTIVE|BSK_BE3C_MMP1_up	TOXCAST_ACTIVE|BSK_BE3C_PAI1_down	TOXCAST_ACTIVE|BSK_CASM3C_HLADR_down	TOXCAST_ACTIVE|BSK_CASM3C_LDLR_down	TOXCAST_ACTIVE|BSK_CASM3C_Proliferation_down	TOXCAST_ACTIVE|BSK_CASM3C_Thrombomodulin_up	TOXCAST_ACTIVE|BSK_CASM3C_uPAR_down	TOXCAST_ACTIVE|BSK_KF3CT_MMP9_down	TOXCAST_ACTIVE|BSK_LPS_PGE2_down	TOXCAST_ACTIVE|BSK_LPS_TissueFactor_up	TOXCAST_ACTIVE|BSK_SAg_CD38_down	TOXCAST_ACTIVE|BSK_SAg_CD40_down	TOXCAST_ACTIVE|BSK_SAg_CD69_down	TOXCAST_ACTIVE|BSK_SAg_Eselectin_up	TOXCAST_ACTIVE|BSK_SAg_IL8_up	TOXCAST_ACTIVE|BSK_SAg_PBMCCytotoxicity_up	TOXCAST_ACTIVE|BSK_SAg_Proliferation_down	TOXCAST_ACTIVE|BSK_SAg_SRB_down	TOXCAST_ACTIVE|BSK_hDFCGF_CollagenIII_down	TOXCAST_ACTIVE|BSK_hDFCGF_MCSF_down	TOXCAST_ACTIVE|BSK_hDFCGF_PAI1_down	TOXCAST_ACTIVE|BSK_hDFCGF_Proliferation_down	TOXCAST_ACTIVE|NVS_ADME_hCYP1A2	TOXCAST_ACTIVE|NVS_ENZ_hBACE	TOXCAST_ACTIVE|NVS_ENZ_hElastase	TOXCAST_ACTIVE|NVS_ENZ_hMAPKAPK2	TOXCAST_ACTIVE|NVS_ENZ_hMMP3	TOXCAST_ACTIVE|NVS_ENZ_hPTPN6_Activator	TOXCAST_ACTIVE|NVS_ENZ_hSIRT1	TOXCAST_ACTIVE|NVS_ENZ_oCOX1	TOXCAST_ACTIVE|NVS_ENZ_rCNOS	TOXCAST_ACTIVE|NVS_ENZ_rMAOAC	TOXCAST_ACTIVE|NVS_GPCR_bDR_NonSelective	TOXCAST_ACTIVE|NVS_GPCR_hDRD4.4	TOXCAST_ACTIVE|NVS_LGIC_rGABAR_NonSelective	TOXCAST_ACTIVE|NVS_MP_hPBR	TOXCAST_ACTIVE|NVS_NR_hAR	TOXCAST_ACTIVE|NVS_NR_hCAR_Antagonist	TOXCAST_ACTIVE|NVS_NR_hPR	TOXCAST_ACTIVE|NVS_TR_hNET	TOXCAST_ACTIVE|OT_AR_ARSRC1_0480	TOXCAST_ACTIVE|OT_AR_ARSRC1_0960	TOXCAST_ACTIVE|OT_ER_ERaERb_0480	TOXCAST_ACTIVE|OT_ER_ERaERb_1440	TOXCAST_ACTIVE|OT_ER_ERbERb_0480	TOXCAST_ACTIVE|OT_ER_ERbERb_1440	TOXCAST_ACTIVE|Tox21_ARE_BLA_agonist_ratio	TOXCAST_ACTIVE|Tox21_AR_LUC_MDAKB2_Agonist	TOXCAST_ACTIVE|Tox21_AhR	TOXCAST_ACTIVE|Tox21_Aromatase_Inhibition	TOXCAST_ACTIVE|Tox21_ELG1_LUC_Agonist	TOXCAST_ACTIVE|Tox21_ERa_LUC_BG1_Agonist	TOXCAST_ACTIVE|Tox21_ESRE_BLA_ratio	TOXCAST_ACTIVE|Tox21_MitochondrialToxicity_ratio	TOXCAST_ACTIVE|Tox21_MitochondrialToxicity_viability	TOXCAST_ACTIVE|Tox21_p53_BLA_p1_ratio	TOXINS_TARGETS|AHR	TOXINS_TARGETS|BE0000077	TOXINS_TARGETS|BE0000123	TOXINS_TARGETS|BE0000132	TOXINS_TARGETS|BE0000372	TOXINS_TARGETS|BE0000694	TOXINS_TARGETS|BE0000792	TOXINS_TARGETS|BE0000956	TOXINS_TARGETS|BE0000988	TOXINS_TARGETS|BE0001111	TOXINS_TARGETS|BE0001116	TOXINS_TARGETS|BE0002433	TOXINS_TARGETS|BE0003380	TOXINS_TARGETS|BE0003543	TOXINS_TARGETS|BE0003721	TOXINS_TARGETS|BE0003848	TOXINS_TARGETS|BE0004796	TOXINS_TARGETS|BE0005490	TOXINS_TARGETS|BE0005532	TOXINS_TARGETS|BE0005553	TOXINS_TARGETS|BE0005805	TOXINS_TARGETS|GNMT	TOXPRINT_STRUCTURE|chain:alkaneCyclic_ethyl_C2_(connect_noZ)	TOXPRINT_STRUCTURE|chain:alkeneCyclic_diene_cyclopentadiene	TOXPRINT_STRUCTURE|chain:aromaticAlkane_Ph-C1_cyclic	TOXPRINT_STRUCTURE|ring:aromatic_benzene	TOXPRINT_STRUCTURE|ring:aromatic_biphenyl	TOXPRINT_STRUCTURE|ring:fused_PAH_acenaphthylene	TOXPRINT_STRUCTURE|ring:fused_PAH_anthracene	TOXPRINT_STRUCTURE|ring:fused_PAH_benz(a)anthracene	TOXPRINT_STRUCTURE|ring:fused_PAH_benzophenanthrene	TOXPRINT_STRUCTURE|ring:fused_PAH_phenanthrene	TOXPRINT_STRUCTURE|ring:fused_PAH_pyrene	TOXPRINT_STRUCTURE|ring:fused_[6_6]_naphthalene
56-55-3	0	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	1	1	0	0	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	1	0	0	1	1	1	0	0	0	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	1	0	1	1	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	1	0	1	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	1	0	0	0	1	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	1	0	1	1	1	1	0	0	0	1	1	1	0	0	0	1	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	1	0	0	1	0	1	0	1	1	0	0	0	0	0	1	0	0	1	0	0	1	0	0	1	0	0	0	0	1	1	1	0	1	1	1	1	1	0	1	1	1	1	1	0	1	1	1	0	0	0	1	0	0	0	0	1	1	1	0	1	0	0	0	1	1	0	0	1	1	1	0	0	1	0	1	1	1	0	1	1	1	1	1	1	1	1	1	1	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1	1	0	1	0	1	1	0	0	1	1	0	0	0	1	0	1	1	0	0	0	0	1	0	0	1	1	0	0	0	1	0	0	1	1	0	0	1	1	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	1	1	0	1	1	0	0	1	0	0	0	0	0	1	1	1	1	0	0	1	0	1	1	0	1	0	1	1	1	0	0	0	0	0	0	0	1	0	1	0	1	1	0	0	0	1	0	0	0	1	0	0	1	1	0	1	0	1
85-01-8	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	1	0	0	0	1	0	0	0	0	1	0	1	1	0	0	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	1	0	0	1	0	1	0	0	0	0	0	1	1	0	1	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	1	1	1	0	0	0	1	0	0	0	1	0	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	1	0	0	1	0	0	0	0	1	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	1	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	1	0	0	0	0	0	0	1	1	1	1	1	0	0	0	0	0	1	0	1	1	0	1	1	1	0	0	0	0	0	0	0	0	1	1	1	0	1	0	0	1	1	1	0	0	1	1	1	0	0	1	0	1	1	1	0	1	1	1	1	1	1	1	1	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	1	0	0	1	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	1
83-32-9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	1	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	1	0	0	1	1	1	0	0	0	0	1	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	1	0	0	0	0	1	1	0	0	0	0	0	0	1	1	0	0	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	1	1	1	1	1	1	1	1	1	1	0	1	1	1	1	0	1	0	0	0	0	0	0	1	1	1	1	1	0	0	0	1	1	0	0	0	0	1	0	1	0	0	1	0	1	1	1	1	1	1	1	1	1	0	0	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	1	1	0	1	1	0	1	0	0	0	0	0	1
129-00-0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	0	0	1	0	1	0	1	0	1	1	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	1	0	1	0	0	0	0	1	1	0	0	0	1	1	0	0	0	0	1	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	1	0	0	0	0	0	1	1	0	1	1	0	0	0	0	0	1	1	1	0	0	1	1	1	0	0	0	0	0	0	0	0	1	1	1	0	1	0	0	0	1	1	1	0	0	0	1	0	0	0	1	1	0	1	0	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	1	1	1	0	0	0	0	0	1	1	0	0	0	1	0	0	1	1	1	1	1	0	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	0	1	0	1	0	1	1	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	1
53-70-3	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	1	0	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	1	1	0	1	0	0	0	0	1	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	1	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	1	0	0	1	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	1	1	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	1	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	1	1	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	1	1	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	1	1	1	1	1	0	1	1	1	1	1	0	1	1	1	0	0	0	1	0	0	0	0	1	1	1	0	1	0	0	0	1	1	0	0	1	1	1	0	0	1	0	1	1	1	0	1	1	1	1	1	1	1	1	1	1	0	0	1	0	0	1	1	1	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	0	0	0	0	1	1	0	1	1	1	0	0	0	0	0	0	0	0	0	1	0	1	0	1	1	0	1	0	0	0	1	0	0	1	1	0	1	0	1
120-12-7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	1	0	1	0	1	1	0	1	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	1	0	0	1	1	0	0	0	0	0	1	1	1	1	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	1	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	1	0	0	0	1	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	1	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	1	0	1	1	0	0	0	0	0	0	1	0	1	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	0	0	0	1	0	1	1	1	0	0	1	1	0	0	1	0	1	1	0	1	1	1	0	0	1	0	0	0	0	0	1	1	1	0	1	0	0	0	1	1	0	0	1	1	1	0	0	1	0	1	1	1	0	0	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	1	0	0	1	0	0	0	0	1
50-32-8	1	1	1	1	1	1	0	0	1	0	1	0	1	1	1	1	0	1	1	1	1	1	1	1	1	0	1	1	1	0	1	1	1	1	1	1	1	1	0	1	0	1	1	1	1	1	1	1	1	1	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0	1	1	0	1	1	0	1	1	1	1	1	1	0	1	1	1	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	1	1	1	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	0	1	0	0	1	0	1	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	1	0	1	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	1	0	0	1	0	0	0	1	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	1	0	0	0	1	0	1	0	0	0	1	0	0	0	0	1	0	0	1	1	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0	0	0	0	0	0	1	1	0	1	1	0	1	1	1	1	1	1	1	0	1	0	1	1	1	1	1	1	1	1	1	0	1	1	1	1	1	0	1	1	1	1	1	0	1	1	1	1	0	0	0	1	1	0	0	1	1	1	0	1	0	0	0	1	1	1	1	1	1	1	0	0	1	0	1	1	1	0	1	1	1	1	1	1	1	1	1	1	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	1	0	1	0	0	0	0	0	1	1	0	1	0	0	0	1	1	0	0	0	1	0	0	1	1	1	1	1	1
206-44-0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	1	1	1	1	1	0	1	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	1	1	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	1	1	0	1	1	0	1	1	1	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1	1	1	0	1	0	1	0	0	1	1	0	0	0	1	1	0	0	1	1	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	1	0	0	0	0	1	0	0	0	1	1	1	1	0	0	1	1	0	1	0	0	1	1	1	0	0	0	0	0	0	0	1	1	1	1	0	1	0	0	0	1	1	0	0	1	0	1	1	1	0	0	1	0	1	1	1	1	1	1	1	1	1	1	0	0	1	1	0	1	1	0	0	0	1	0	1	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	1	1	0	0	0	1	0	0	0	1	0	0	0	0	1	0	1	0	1	1	1	1	0	1	1	1	0	0	0	1	0	0	1	1	0	0	1	1	0	0	0	1	0	0	1	1	0	1	1	1	1	1	1	0	1	1	1	1	0	0	1	0	0	1	0	0	0	0	0	0	0	1	1	0	1	1	1	1	1	1	0	0	0	0	0	1	1	1	0	0	1	0	0	1	1	0	0	0	1	0	1	0	0	0	1	0	1	0	0	0	0	1	0	1	0	1	1	1	0	0	0	0	0	1
191-24-2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	1	1	1	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	1	1	1	0	0	0	0	0	1	1	1	0	0	0	0	1	1	0	0	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	0	1	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	1	0	0	0	0	1	1	1	1	0	0	1	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	1	1	0	1	0	0	0	1	1	1	0	0	1	1	1	0	0	0	1	0	0	0	0	1	1	1	0	1	1	1	0	1	1	0	0	0	0	1	0	0	0	0	1	0	1	0	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	1	0	0	1	0	0	1	1	1
218-01-9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	1	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	1	0	0	1	0	0	1	0	0	1	0	0	0	1	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	1	1	0	0	0	1	1	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	1	0	0	0	0	0	1	0	1	1	0	1	1	1	0	0	0	0	0	0	1	0	1	1	1	0	1	0	0	1	1	1	0	0	1	1	1	0	0	1	0	1	1	1	0	1	1	1	1	1	1	1	1	1	1	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	1	1	0	1
